<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pathogens</journal-id><journal-id journal-id-type="iso-abbrev">Pathogens</journal-id><journal-id journal-id-type="publisher-id">pathogens</journal-id><journal-title-group><journal-title>Pathogens</journal-title></journal-title-group><issn pub-type="epub">2076-0817</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7909252</article-id><article-id pub-id-type="pmid">33498299</article-id><article-id pub-id-type="doi">10.3390/pathogens10020091</article-id><article-id pub-id-type="publisher-id">pathogens-10-00091</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Novel Treatments and Preventative Strategies Against Food-Poisoning Caused by Staphylococcal Species</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4926-3891</contrib-id><name><surname>Mourenza</surname><given-names>&#x000c1;lvaro</given-names></name><xref ref-type="aff" rid="af1-pathogens-10-00091">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5069-2637</contrib-id><name><surname>Gil</surname><given-names>Jos&#x000e9; A.</given-names></name><xref ref-type="aff" rid="af1-pathogens-10-00091">1</xref><xref ref-type="aff" rid="af2-pathogens-10-00091">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7763-582X</contrib-id><name><surname>Mateos</surname><given-names>Luis M.</given-names></name><xref ref-type="aff" rid="af1-pathogens-10-00091">1</xref><xref ref-type="aff" rid="af2-pathogens-10-00091">2</xref><xref rid="c1-pathogens-10-00091" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9509-5174</contrib-id><name><surname>Letek</surname><given-names>Michal</given-names></name><xref ref-type="aff" rid="af1-pathogens-10-00091">1</xref><xref ref-type="aff" rid="af3-pathogens-10-00091">3</xref><xref rid="c1-pathogens-10-00091" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-pathogens-10-00091"><label>1</label>Departamento de Biolog&#x000ed;a Molecular, &#x000c1;rea de Microbiolog&#x000ed;a, Universidad de Le&#x000f3;n, 24071 Le&#x000f3;n, Spain; <email>amouf@unileon.es</email> (&#x000c1;.M.); <email>jagils@unileon.es</email> (J.A.G.)</aff><aff id="af2-pathogens-10-00091"><label>2</label>Instituto de Biolog&#x000ed;a Molecular, Gen&#x000f3;mica y Prote&#x000f3;mica (INBIOMIC), Universidad de Le&#x000f3;n, 24071 Le&#x000f3;n, Spain</aff><aff id="af3-pathogens-10-00091"><label>3</label>Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de Le&#x000f3;n, 24071 Le&#x000f3;n, Spain</aff><author-notes><corresp id="c1-pathogens-10-00091"><label>*</label>Correspondence: <email>luis.mateos@unileon.es</email> (L.M.M.); <email>michal.letek@unileon.es</email> (M.L.)</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2021</year></pub-date><volume>10</volume><issue>2</issue><elocation-id>91</elocation-id><history><date date-type="received"><day>31</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>16</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Staphylococcal infections are a widespread cause of disease in humans. In particular, <italic>S. aureus</italic> is a major causative agent of infection in clinical medicine. In addition, these bacteria can produce a high number of staphylococcal enterotoxins (SE) that may cause food intoxications. Apart from <italic>S. aureus</italic>, many coagulase-negative <italic>Staphylococcus</italic> spp. could be the source of food contamination. Thus, there is an active research work focused on developing novel preventative interventions based on food supplements to reduce the impact of staphylococcal food poisoning. Interestingly, many plant-derived compounds, such as polyphenols, flavonoids, or terpenoids, show significant antimicrobial activity against staphylococci, and therefore these compounds could be crucial to reduce the incidence of food intoxication in humans. Here, we reviewed the most promising strategies developed to prevent staphylococcal food poisoning.</p></abstract><kwd-group><kwd><italic>Staphylococcus</italic></kwd><kwd>enterotoxins</kwd><kwd>food-poisoning</kwd><kwd>natural compounds</kwd><kwd>preventative strategies</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-pathogens-10-00091"><title>1. Introduction</title><p>The bacteria belonging to the genus <italic>Staphylococcus</italic> are generally classified as coagulase-positive or coagulase-negative species. Among all of them, <italic>Staphylococcus aureus</italic> is the leading cause of human disease. Moreover, staphylococcal food poisoning (SFP) is a common disease, and the number of cases had increased continuously since 1884 when the first case was reported to become one of the most common causes of foodborne disease [<xref rid="B1-pathogens-10-00091" ref-type="bibr">1</xref>]. In addition, coagulase-negative staphylococci and their toxins could also be an important source of food contamination, particularly in ready-to-eat products, milk, cheese, milk chocolate, or canned meat [<xref rid="B2-pathogens-10-00091" ref-type="bibr">2</xref>,<xref rid="B3-pathogens-10-00091" ref-type="bibr">3</xref>,<xref rid="B4-pathogens-10-00091" ref-type="bibr">4</xref>,<xref rid="B5-pathogens-10-00091" ref-type="bibr">5</xref>,<xref rid="B6-pathogens-10-00091" ref-type="bibr">6</xref>,<xref rid="B7-pathogens-10-00091" ref-type="bibr">7</xref>,<xref rid="B8-pathogens-10-00091" ref-type="bibr">8</xref>,<xref rid="B9-pathogens-10-00091" ref-type="bibr">9</xref>]. This may lead to food intoxication due to the presence of staphylococcal exotoxins, which were firstly identified in 1992 [<xref rid="B7-pathogens-10-00091" ref-type="bibr">7</xref>]. Moreover, the inappropriate manipulation of fresh food may lead to outbreaks originated in restaurants because <italic>S. aureus</italic> could also be transmitted from human carriers during food handling [<xref rid="B10-pathogens-10-00091" ref-type="bibr">10</xref>,<xref rid="B11-pathogens-10-00091" ref-type="bibr">11</xref>]. Furthermore, food production animals, including pigs, cattle, or chickens, may also be carriers of <italic>S. aureus</italic> [<xref rid="B1-pathogens-10-00091" ref-type="bibr">1</xref>]. In fact, the use of antibiotics in animal production has increased the incidence of livestock-associated antibiotic-resistant strains [<xref rid="B1-pathogens-10-00091" ref-type="bibr">1</xref>,<xref rid="B12-pathogens-10-00091" ref-type="bibr">12</xref>,<xref rid="B13-pathogens-10-00091" ref-type="bibr">13</xref>]. </p><p>The existence of a robust and straightforward PCR test that detects microorganisms with genes that encode exotoxins has allowed the detection of hundreds of staphylococcal food-poisoning outbreaks every year [<xref rid="B14-pathogens-10-00091" ref-type="bibr">14</xref>]. However, a high exotoxin production is not directly correlated with a higher disease incidence. Therefore, other alternative analytical methods have been routinely employed to identify the presence of exotoxins in food, including those based on high-performance liquid chromatography (HPLC) and mass spectrometry (MS) [<xref rid="B15-pathogens-10-00091" ref-type="bibr">15</xref>]. Unfortunately, there is a wide range of exotoxins produced by pathogens from the staphylococcal group, making it challenging to identify the origin of the food intoxication [<xref rid="B6-pathogens-10-00091" ref-type="bibr">6</xref>]. </p><p>Moreover, the pasteurization of food destroys staphylococci, but it usually does not affect exotoxins&#x02019; activity, which may still cause disease in humans after food processing [<xref rid="B6-pathogens-10-00091" ref-type="bibr">6</xref>]. Besides, some <italic>S. aureus</italic> strains can resist high concentrations of lactic acid, which facilitates their growth in various foods, including cheese, meat, salads, or milk chocolate [<xref rid="B1-pathogens-10-00091" ref-type="bibr">1</xref>,<xref rid="B9-pathogens-10-00091" ref-type="bibr">9</xref>,<xref rid="B15-pathogens-10-00091" ref-type="bibr">15</xref>,<xref rid="B16-pathogens-10-00091" ref-type="bibr">16</xref>]. </p><p>In addition, coagulase-negative staphylococci in food are important reservoirs of antimicrobial resistance genes, virulence factors, and exotoxins [<xref rid="B3-pathogens-10-00091" ref-type="bibr">3</xref>,<xref rid="B17-pathogens-10-00091" ref-type="bibr">17</xref>,<xref rid="B18-pathogens-10-00091" ref-type="bibr">18</xref>]. This is now considered a significant health problem because these genes could be horizontally transmitted to coagulase-positive staphylococci, which may increase the incidence of foodborne disease [<xref rid="B17-pathogens-10-00091" ref-type="bibr">17</xref>,<xref rid="B19-pathogens-10-00091" ref-type="bibr">19</xref>,<xref rid="B20-pathogens-10-00091" ref-type="bibr">20</xref>,<xref rid="B21-pathogens-10-00091" ref-type="bibr">21</xref>].</p><p>In summary, there is a great interest in developing novel ways of preventing the presence of <italic>Staphylococcus</italic> spp. and their exotoxins in food to reduce the incidence of intoxications. Natural compounds used as food supplements are now considered an up-and-coming strategy to decrease the staphylococcal colonization of food. </p></sec><sec id="sec2-pathogens-10-00091"><title>2. Staphylococcal Enterotoxins and Virulence Factors</title><p><italic>Staphylococcus</italic> spp. exotoxins present in food are a group of low-molecular-weight pyrogenic proteins of around 22&#x02013;29 kDa, with important similarities in their secondary and tertiary structures [<xref rid="B1-pathogens-10-00091" ref-type="bibr">1</xref>,<xref rid="B17-pathogens-10-00091" ref-type="bibr">17</xref>,<xref rid="B22-pathogens-10-00091" ref-type="bibr">22</xref>,<xref rid="B23-pathogens-10-00091" ref-type="bibr">23</xref>,<xref rid="B24-pathogens-10-00091" ref-type="bibr">24</xref>]. These exotoxins are grouped into three different families depending on their aminoacidic sequence: Staphylococcal enterotoxins (SE), Staphylococcal enterotoxin-like (SEl), and the toxic shock syndrome toxin 1 (TSST-1) [<xref rid="B1-pathogens-10-00091" ref-type="bibr">1</xref>]. Other toxins related to TSST-1 but showing a different mechanism of action have now been classified as staphylococcal superantigen-like (SSl) [<xref rid="B24-pathogens-10-00091" ref-type="bibr">24</xref>]. </p><p>Different species of <italic>Staphylococcus</italic> can produce exotoxins, including coagulase-negative strains that are considered non-pathogenic. However, picomolar concentrations of SEs can cause toxic shock syndrome (TSS), fever, hypotension, and multi-organ failure that enhance the disease caused by <italic>S. aureus</italic> [<xref rid="B25-pathogens-10-00091" ref-type="bibr">25</xref>,<xref rid="B26-pathogens-10-00091" ref-type="bibr">26</xref>]. In addition, the SE and TSST-1 are also considered superantigens (SAgs) because they have the potential to activate T cells through a complex signaling pathway and stimulate a hyper-inflammatory response [<xref rid="B24-pathogens-10-00091" ref-type="bibr">24</xref>,<xref rid="B27-pathogens-10-00091" ref-type="bibr">27</xref>]. SAgs are implicated in the development of sepsis, infective endocarditis, and other complications [<xref rid="B28-pathogens-10-00091" ref-type="bibr">28</xref>]. </p><p>Among all staphylococcal toxins, SEs have been the most frequently associated with foodborne diseases, causing emesis and T-cell activation [<xref rid="B29-pathogens-10-00091" ref-type="bibr">29</xref>]. There are at least 26 different SEs characterized, but this number could be even higher [<xref rid="B10-pathogens-10-00091" ref-type="bibr">10</xref>]. These toxins are resistant to heat and acidity and to the hydrolysis mediated by most proteolytic enzymes [<xref rid="B1-pathogens-10-00091" ref-type="bibr">1</xref>,<xref rid="B17-pathogens-10-00091" ref-type="bibr">17</xref>]. </p><p>While SEs and TSST-1 directly activate macrophages and T-cells, SEl and SSl are considered capable of general immunomodulation [<xref rid="B24-pathogens-10-00091" ref-type="bibr">24</xref>]. However, SEl proteins can induce neither emesis nor T-cell activation [<xref rid="B27-pathogens-10-00091" ref-type="bibr">27</xref>]. Moreover, some staphylococcal toxins show a proapoptotic activity essential for <italic>S. aureus</italic> colonization [<xref rid="B27-pathogens-10-00091" ref-type="bibr">27</xref>]. SEs may cause cytotoxicity in intestinal cells, which results in gastroenteritis, vomiting, and gastric inflammation [<xref rid="B29-pathogens-10-00091" ref-type="bibr">29</xref>]. </p><p>Despite that coagulase-negative strains could be involved in food-poisoning and may even release toxins that cause the lethal toxic shock syndrome [<xref rid="B4-pathogens-10-00091" ref-type="bibr">4</xref>,<xref rid="B22-pathogens-10-00091" ref-type="bibr">22</xref>,<xref rid="B30-pathogens-10-00091" ref-type="bibr">30</xref>], <italic>S. aureus</italic> is still considered the leading cause of staphylococcal gastroenteritis and food intoxication [<xref rid="B7-pathogens-10-00091" ref-type="bibr">7</xref>,<xref rid="B9-pathogens-10-00091" ref-type="bibr">9</xref>]. There are important outbreaks caused periodically by <italic>S. aureus</italic> and its toxins, and in most cases, the staphylococcal enterotoxin A (SEA) is involved [<xref rid="B5-pathogens-10-00091" ref-type="bibr">5</xref>,<xref rid="B7-pathogens-10-00091" ref-type="bibr">7</xref>]. </p><p>In addition, other virulence factors encoded in the genome of different staphylococcal strains could be putative sources of gastrointestinal diseases. In fact, several virulence factors are essential for the successful colonization of the host, including coagulase, staphylokinase, adhesins, protein A, and <italic>&#x003b2;</italic>-hemolysin [<xref rid="B31-pathogens-10-00091" ref-type="bibr">31</xref>,<xref rid="B32-pathogens-10-00091" ref-type="bibr">32</xref>,<xref rid="B33-pathogens-10-00091" ref-type="bibr">33</xref>]. Their expression is under the control of several regulatory genes and sometimes under the control of noncoding RNAs. The expression of this plethora of virulence factors is indirectly regulated by pH, temperature, and other changing conditions that the pathogen encounters in food or during infection [<xref rid="B31-pathogens-10-00091" ref-type="bibr">31</xref>,<xref rid="B34-pathogens-10-00091" ref-type="bibr">34</xref>]. </p><p>Finally, discovering the toxin-antitoxin (TA) system has revolutionized the search for novel therapies against staphylococci [<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>]. The TA system is composed mainly of two genes encoding an antitoxin (usually located upstream of an operon) and the toxin (located downstream). The first gene is self-regulated, and both the antitoxin and the toxin-antitoxin complex may repress the TA operon&#x02019;s promoter [<xref rid="B36-pathogens-10-00091" ref-type="bibr">36</xref>,<xref rid="B37-pathogens-10-00091" ref-type="bibr">37</xref>]. During infection, the host proteases degrade the antitoxin protein, enabling the expression of the toxin [<xref rid="B36-pathogens-10-00091" ref-type="bibr">36</xref>]. There is much interest in developing treatments that may inhibit the antitoxin protein&#x02019;s degradation or even block the antitoxin-toxin interactions, which could be a natural and broad-spectrum antibacterial treatment [<xref rid="B36-pathogens-10-00091" ref-type="bibr">36</xref>,<xref rid="B37-pathogens-10-00091" ref-type="bibr">37</xref>].</p></sec><sec id="sec3-pathogens-10-00091"><title>3. Treatments Against Staphylococcal Food Poisoning</title><p>Traditionally, the treatments against staphylococcal food-poisoning are focused on either controlling exotoxins or the control of the transmission of the bacteria. The use of antimicrobials to treat staphylococcal food intoxications is not recommended due to the additional release of staphylococcal toxins after bacterial cell death, leading to septic shock. Besides, if antibiotic therapy is administered to patients infected by multidrug-resistant staphylococci, this could facilitate colonization of the gastrointestinal tract once the sensitive intestinal flora is altered. Consequently, antimicrobial-resistant staphylococci may then replicate and secrete more toxins that could aggravate the disease [<xref rid="B38-pathogens-10-00091" ref-type="bibr">38</xref>]. </p><sec id="sec3dot1-pathogens-10-00091"><title>3.1. Monoclonal Antibodies and Vaccines</title><p><italic>S. aureus</italic> is a natural commensal of the human skin; however, it can circumvent the host immune system, and it is a facultative intracellular pathogen [<xref rid="B39-pathogens-10-00091" ref-type="bibr">39</xref>]. These two aspects of the pathogenesis of <italic>S. aureus</italic> are the main causes of the failure of all vaccine candidates tested in humans and based on opsonization [<xref rid="B40-pathogens-10-00091" ref-type="bibr">40</xref>,<xref rid="B41-pathogens-10-00091" ref-type="bibr">41</xref>,<xref rid="B42-pathogens-10-00091" ref-type="bibr">42</xref>]. However, the production of antibodies against staphylococcal extracellular proteins protect patients against sepsis caused by <italic>S. aureus</italic> [<xref rid="B43-pathogens-10-00091" ref-type="bibr">43</xref>]. Therefore, the development of monoclonal antibodies-based therapies against specific staphylococcal toxins is now considered a very promising strategy to generate protection against <italic>S. aureus</italic> [<xref rid="B44-pathogens-10-00091" ref-type="bibr">44</xref>]. Importantly, this strategy has been successfully tested in clinical trials against toxins from <italic>Clostridium difficile</italic> or <italic>Escherichia coli</italic> [<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>]. </p><p>Monoclonal antibodies-based therapies are effective against many other bacteria [<xref rid="B45-pathogens-10-00091" ref-type="bibr">45</xref>,<xref rid="B46-pathogens-10-00091" ref-type="bibr">46</xref>], particularly against the most virulent species [<xref rid="B46-pathogens-10-00091" ref-type="bibr">46</xref>]. However, due to the high number of toxins produced by <italic>S. aureus</italic>, it is becoming clear that therapies based on monoclonal antibodies targeting a single toxin are frequently ineffective [<xref rid="B25-pathogens-10-00091" ref-type="bibr">25</xref>]. Therefore, there is interest in developing combinatorial therapies against multiple <italic>S. aureus</italic> enterotoxins and other virulence factors, including extracellular or cell-wall anchored proteins [<xref rid="B42-pathogens-10-00091" ref-type="bibr">42</xref>,<xref rid="B45-pathogens-10-00091" ref-type="bibr">45</xref>,<xref rid="B47-pathogens-10-00091" ref-type="bibr">47</xref>,<xref rid="B48-pathogens-10-00091" ref-type="bibr">48</xref>,<xref rid="B49-pathogens-10-00091" ref-type="bibr">49</xref>,<xref rid="B50-pathogens-10-00091" ref-type="bibr">50</xref>,<xref rid="B51-pathogens-10-00091" ref-type="bibr">51</xref>]. In particular, monoclonal antibodies-based therapies have been developed against multiple staphylococcal enterotoxins and TSST-1 [<xref rid="B42-pathogens-10-00091" ref-type="bibr">42</xref>,<xref rid="B51-pathogens-10-00091" ref-type="bibr">51</xref>,<xref rid="B52-pathogens-10-00091" ref-type="bibr">52</xref>]. Some of these therapies are undergoing clinical trials [<xref rid="B45-pathogens-10-00091" ref-type="bibr">45</xref>]. This type of therapy could also be used to prevent the spread of the disease in animals infected by livestock-associated multidrug-resistant strains [<xref rid="B53-pathogens-10-00091" ref-type="bibr">53</xref>]. However, the high cost of this type of treatment makes this strategy difficult to be implemented in animal production. </p><p>In addition, some studies have been focused on developing immunotherapies targeting the staphylococcal &#x003b1;-toxin [<xref rid="B42-pathogens-10-00091" ref-type="bibr">42</xref>]. This is based on recent evidence showing a high titter of anti-&#x003b1;-toxin antibodies protect against future infections. However, a vaccine developed against different variants of the &#x003b1;-toxin was not effective in humans, despite that it provided effective protection in mouse pneumonia models [<xref rid="B54-pathogens-10-00091" ref-type="bibr">54</xref>,<xref rid="B55-pathogens-10-00091" ref-type="bibr">55</xref>]. Nevertheless, these results support the development of multi-target immunotherapies. </p><p>Interestingly, TSST-1 is another important target for the development of immunotherapies. Similar to &#x003b1;-toxin, it has been demonstrated that antibodies generated against TSST-1 may protect patients against future infections [<xref rid="B56-pathogens-10-00091" ref-type="bibr">56</xref>,<xref rid="B57-pathogens-10-00091" ref-type="bibr">57</xref>]. Accordingly, 80% of the human population develops antibodies against TSST-1 during the first years of life [<xref rid="B58-pathogens-10-00091" ref-type="bibr">58</xref>]. A vaccine has been developed to provide immunity against TSST-1 in the remaining 20% of the population, which is also undergoing clinical trials [<xref rid="B59-pathogens-10-00091" ref-type="bibr">59</xref>,<xref rid="B60-pathogens-10-00091" ref-type="bibr">60</xref>].</p><p>Other interesting targets for immunotherapy-based strategies are virulence factors such as the iron-regulated surface determinants (Isd) proteins, which are located on the extracellular matrix of biofilms produced by <italic>S. aureus</italic> [<xref rid="B61-pathogens-10-00091" ref-type="bibr">61</xref>]. Moreover, the toxin-antitoxin system could be disrupted by monoclonal antibodies that bind to the toxin but not to the antitoxin [<xref rid="B36-pathogens-10-00091" ref-type="bibr">36</xref>].</p><p>Overall, monoclonal antibodies showed promising results in animal models, but data from clinical trials in humans are still not available or conclusive [<xref rid="B48-pathogens-10-00091" ref-type="bibr">48</xref>,<xref rid="B61-pathogens-10-00091" ref-type="bibr">61</xref>]. However, a cocktail of monoclonal antibodies protects mice from <italic>S. aureus</italic> infections very efficiently [<xref rid="B48-pathogens-10-00091" ref-type="bibr">48</xref>,<xref rid="B61-pathogens-10-00091" ref-type="bibr">61</xref>]. </p></sec><sec id="sec3dot2-pathogens-10-00091"><title>3.2. Natural Compounds Against Staphylococcal Infections</title><p>As mentioned above, a plethora of toxins, virulence factors, and antimicrobial resistance traits make <italic>S. aureus</italic> a principal cause of foodborne disease. In addition, the biofilm structures created by this pathogen increase its resistance to antimicrobials [<xref rid="B62-pathogens-10-00091" ref-type="bibr">62</xref>,<xref rid="B63-pathogens-10-00091" ref-type="bibr">63</xref>]. Fortunately, there is an increasing body of knowledge on natural compounds derived from plants or microorganisms that could be used as dietary supplements to prevent staphylococcal infections and the spreading of their antimicrobial resistance. </p><p>In general, the therapeutic strategies based on natural compounds could be classified by their mode of action in antimicrobial or anti-virulence therapies [<xref rid="B64-pathogens-10-00091" ref-type="bibr">64</xref>]. Antimicrobial therapies act directly on the bacteria to inhibit their growth, whereas anti-virulence therapies are based on inhibitors of bacterial virulence factors [<xref rid="B65-pathogens-10-00091" ref-type="bibr">65</xref>]. Importantly, anti-virulence therapies do not directly affect bacterial fitness, and therefore they elicit a limited evolutionary pressure that reduces the development of resistance [<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>].</p><p>Many natural compounds directly inhibit bacterial growth or replication. In particular, polyphenols are very well-known antimicrobial compounds present in significant concentrations in plants (<xref rid="pathogens-10-00091-t001" ref-type="table">Table 1</xref>). Importantly, the combination of polyphenols with other antimicrobial compounds may be synergistic [<xref rid="B62-pathogens-10-00091" ref-type="bibr">62</xref>], making them very attractive candidates for the development of combinatorial strategies used to prevent staphylococcal food contamination. </p><p>Some of these compounds repress SEs production, whereas others directly interact with enterotoxins and inhibit their mechanism of action. Some of the latter could be used as additives to inhibit SEs-derived food intoxication, particularly in products treated with sterilization or pasteurization processes where staphylococci may be killed. However, their already secreted exotoxins could still be active in contaminated food [<xref rid="B1-pathogens-10-00091" ref-type="bibr">1</xref>]. Therefore, enterotoxin-directed treatments can be used against <italic>S. aureus</italic>-contaminated and SEs-contaminated food [<xref rid="B25-pathogens-10-00091" ref-type="bibr">25</xref>], whereas treatments that alter the expression of the genes encoding enterotoxins expression are not effective once SEs are already present in food.</p><p>For example, the Muscadine grape&#x02019;s skin is rich in gallic and ellagic acids, which show significant antimicrobial activity against <italic>S. aureus</italic> [<xref rid="B62-pathogens-10-00091" ref-type="bibr">62</xref>]. The crude extracts of other plant species such as <italic>Chenopodium album</italic> are rich in phenolic and flavonoid compounds with powerful antibacterial activity against <italic>S. aureus</italic>, equivalent to many antibiotics used in clinical medicine [<xref rid="B66-pathogens-10-00091" ref-type="bibr">66</xref>]. Aloe vera, black garlic, eucalyptus, or grape seeds could be the source of many other natural compounds with antimicrobial activity [<xref rid="B64-pathogens-10-00091" ref-type="bibr">64</xref>]. This is due to phenolic and phenolic-derivative compounds and alkaloids, fatty acids, organo-sulfurs, and other aliphatic and cyclic compounds that in total amount to hundreds of molecules with anti-staphylococcal activity [<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>,<xref rid="B64-pathogens-10-00091" ref-type="bibr">64</xref>]. </p><p>In addition, some of these plant-derived compounds show activity against SEs [<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>], which is essential to achieve an all-in-one strategy against staphylococcal food poisoning (<xref rid="pathogens-10-00091-t001" ref-type="table">Table 1</xref>). For example, tomatidine is a well-known antibacterial compound with demonstrated activity against <italic>S. aureus</italic> [<xref rid="B67-pathogens-10-00091" ref-type="bibr">67</xref>]. Tomatidine is a steroidal alkaloid found in different solanaceous plants, which was first described as a bactericidal agent against small-colony variants of <italic>S. aureus</italic> [<xref rid="B68-pathogens-10-00091" ref-type="bibr">68</xref>]. However, tomatidine is also a quorum-sensing inhibitor, which alters the expression of many virulence factors, including some toxins [<xref rid="B69-pathogens-10-00091" ref-type="bibr">69</xref>]. Similarly, the expression of the staphylococcal &#x003b1;-toxin is controlled by allicin, capsaicin, and other amide-derived alkaloids present in chili peppers [<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>,<xref rid="B70-pathogens-10-00091" ref-type="bibr">70</xref>], another solanaceous plant. </p><p>Interestingly, anisodamine is an alkaloid produced by a Chinese herb that reduces the TSST-1 concentration in serum and the risk of toxic shock syndrome [<xref rid="B71-pathogens-10-00091" ref-type="bibr">71</xref>]. Anisodamine is an immunomodulator that inhibits the expression of cytokines such as tumor necrosis factor alpha (TNF-&#x003b1;), interleukin 1 beta (IL-1&#x003b2;), interleukin 8 (IL-8), interleukin 2 (IL-2), and interferon gamma (IFN-&#x003b3;) expression in a dose-dependent manner, which may eventually reduce the effects of the cytokine storm induced during the toxic shock syndrome [<xref rid="B71-pathogens-10-00091" ref-type="bibr">71</xref>,<xref rid="B72-pathogens-10-00091" ref-type="bibr">72</xref>]. </p><table-wrap id="pathogens-10-00091-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">pathogens-10-00091-t001_Table 1</object-id><label>Table 1</label><caption><p>Natural sources of active compounds that could be useful to prevent staphylococcal-food poisoning.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Natural Sources</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Active Compounds</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Targets</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Muscadine grape</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gallic and ellagic acids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B62-pathogens-10-00091" ref-type="bibr">62</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chenopodium album</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenolic compounds<break/>Flavonoid compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-pathogens-10-00091" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Citrus fruits, grapes, and tomatoes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tomatidine<break/>Naringenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B69-pathogens-10-00091" ref-type="bibr">69</xref>,<xref rid="B73-pathogens-10-00091" ref-type="bibr">73</xref>,<xref rid="B74-pathogens-10-00091" ref-type="bibr">74</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fermented orange juice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Naringenin-glycosylated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-pathogens-10-00091" ref-type="bibr">75</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Garlic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Allicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-pathogens-10-00091" ref-type="bibr">70</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chili peppers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Capsaicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chinese herbs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anisodamine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SEs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-pathogens-10-00091" ref-type="bibr">71</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Licorice root</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Licochalcone A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B76-pathogens-10-00091" ref-type="bibr">76</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Olive oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-hydroxytyrosol<break/>Tyrosol<break/>Vanillic acid<break/>p-coumaric acid<break/>4-(acetoxyethyl)-1,2-dihydroxybenzene<break/>Pinoresinol<break/>1-acetoxypinoresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Salmonella enterica</italic>
<break/>
<italic>Listeria monocytogenes</italic>
<break/>
<italic>E. coli</italic>
<break/>
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-pathogens-10-00091" ref-type="bibr">77</xref>,<xref rid="B78-pathogens-10-00091" ref-type="bibr">78</xref>,<xref rid="B79-pathogens-10-00091" ref-type="bibr">79</xref>,<xref rid="B80-pathogens-10-00091" ref-type="bibr">80</xref>,<xref rid="B81-pathogens-10-00091" ref-type="bibr">81</xref>,<xref rid="B82-pathogens-10-00091" ref-type="bibr">82</xref>,<xref rid="B83-pathogens-10-00091" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clove oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eugenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SEs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B84-pathogens-10-00091" ref-type="bibr">84</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resveratrol<break/>Tannins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-toxin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>,<xref rid="B85-pathogens-10-00091" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mentha</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Menthol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SEs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-pathogens-10-00091" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hop plant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xanthohumol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-pathogens-10-00091" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mustard</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Allylisothiocyanate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
<break/>
<italic>Pseudomonas aeruginosa</italic>
<break/>
<italic>E. coli</italic>
<break/>
<italic>L. monocytogenes</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B88-pathogens-10-00091" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aloe vera</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aloeemodin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-pathogens-10-00091" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eucalyptus, Mimosa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pyroligenous acids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
<break/>
<italic>E. coli</italic>
<break/>
<italic>P. aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-pathogens-10-00091" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Caloboletus radicans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8-deacetylcyclocalopin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-pathogens-10-00091" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Pleurotus sajor-caju</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic>-hydroxybenzoic acid<break/><italic>p</italic>-coumaric acid<break/>Cinnamic acid </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-pathogens-10-00091" ref-type="bibr">90</xref>,<xref rid="B91-pathogens-10-00091" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Honey</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrogen peroxide<break/>Gluconic acid<break/>Polyphenols</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multiple bacteria<break/><italic>S. aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-pathogens-10-00091" ref-type="bibr">92</xref>,<xref rid="B93-pathogens-10-00091" ref-type="bibr">93</xref>,<xref rid="B94-pathogens-10-00091" ref-type="bibr">94</xref>,<xref rid="B95-pathogens-10-00091" ref-type="bibr">95</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Propolis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyphenols<break/>Waxes<break/>Resins<break/>Polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>E. coli</italic>
<break/>
<italic>S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-pathogens-10-00091" ref-type="bibr">96</xref>,<xref rid="B97-pathogens-10-00091" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Other natural sources</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cinnamaldehyde<break/>Baicalein<break/>Apicidin<break/>&#x003b1;-cyperone<break/>Avellanin C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quorum sensing<break/><italic>S. aureus</italic><break/><italic>Bacillus sp.</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-pathogens-10-00091" ref-type="bibr">64</xref>,<xref rid="B98-pathogens-10-00091" ref-type="bibr">98</xref>,<xref rid="B99-pathogens-10-00091" ref-type="bibr">99</xref>]</td></tr></tbody></table></table-wrap><p>Moreover, phenolic compounds (in particular, many flavonoids) could be used to control the hemolytic activity and secretion of some SEs (<xref rid="pathogens-10-00091-t001" ref-type="table">Table 1</xref>). For example, licochalcone A may decrease the expression and secretion of SEA and SEB in a dose-dependent manner, and consequently, the release of TNF-&#x003b1;, which ameliorates the adverse effects of these enterotoxins [<xref rid="B76-pathogens-10-00091" ref-type="bibr">76</xref>]. </p><p>Naringenin is another well-studied natural flavonoid that is present in citrus fruits and tomatoes. Naringenin presents a low antimicrobial activity against <italic>S. aureus</italic>, but it can also inhibit the &#x003b1;-toxin expression at subinhibitory concentrations [<xref rid="B73-pathogens-10-00091" ref-type="bibr">73</xref>,<xref rid="B74-pathogens-10-00091" ref-type="bibr">74</xref>]. However, the main handicap of naringenin is its low solubility and, therefore, low oral bioavailability. Nevertheless, the functionalization of the molecule with certain lipophilic groups may enhance its biochemical properties [<xref rid="B100-pathogens-10-00091" ref-type="bibr">100</xref>]. Furthermore, naringenin-glycosylated forms present in fermented orange juice increase this compound&#x02019;s absorption profile from the diet [<xref rid="B75-pathogens-10-00091" ref-type="bibr">75</xref>]. </p><p>Moreover, olive oil possesses many phenolic compounds with important antimicrobial activities, and therefore it is considered a great natural product used for food preservation [<xref rid="B77-pathogens-10-00091" ref-type="bibr">77</xref>]. The antimicrobial activity of commercial olive oil has been tested against many different bacterial pathogens (<xref rid="pathogens-10-00091-t001" ref-type="table">Table 1</xref>)<italic>,</italic> showing activity against all of them in broth cultures when small quantities of olive oils are added [<xref rid="B78-pathogens-10-00091" ref-type="bibr">78</xref>]. </p><p>The antimicrobial activity of polyphenols contained in olive oil has been clearly demonstrated [<xref rid="B79-pathogens-10-00091" ref-type="bibr">79</xref>,<xref rid="B80-pathogens-10-00091" ref-type="bibr">80</xref>,<xref rid="B81-pathogens-10-00091" ref-type="bibr">81</xref>]. For example, 4-hydroxytyrosol is a phenolic derivative found in olives that shows SEA-inhibition and bactericidal activity [<xref rid="B82-pathogens-10-00091" ref-type="bibr">82</xref>]. This compound may be found in plant crude extracts but also in edible olives. However, the polyphenols content can vary depending on the species used, the degree of maturation of its fruits, and the irrigation system used during olive cultivation [<xref rid="B79-pathogens-10-00091" ref-type="bibr">79</xref>,<xref rid="B81-pathogens-10-00091" ref-type="bibr">81</xref>]. </p><p>Apart from 4-hydroxytyrosol, the most common phenolic compounds found in olive oil are tyrosol, vanillic acid, p-coumaric, 4-(acetoxyethyl)-1,2-dihydrxybenzene, pinoresinol, and 1-acetoxypinoresinol [<xref rid="B77-pathogens-10-00091" ref-type="bibr">77</xref>,<xref rid="B79-pathogens-10-00091" ref-type="bibr">79</xref>,<xref rid="B80-pathogens-10-00091" ref-type="bibr">80</xref>,<xref rid="B81-pathogens-10-00091" ref-type="bibr">81</xref>,<xref rid="B83-pathogens-10-00091" ref-type="bibr">83</xref>]. Due to its complex and variable composition, the olive oil&#x02019;s polyphenols are collectively named olive oil polyphenol extract (OOPE). </p><p>Other plant-derived polyphenols include eugenol, which is found in clove oil and represses the expression of the genes that encode SEA, SEB, and TSST-1 at subinhibitory concentrations [<xref rid="B84-pathogens-10-00091" ref-type="bibr">84</xref>]. Wine-derived phenolic compounds such as the stilbenoids (e.g., resveratrol) and tannins showed anti-hemolytic activity [<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>,<xref rid="B85-pathogens-10-00091" ref-type="bibr">85</xref>]. Moreover, menthol is a terpene alcohol from plants of the <italic>Mentha</italic> genus that also inhibits the expression of genes encoding exotoxins, specially &#x003b1;-hemolysin, SEA, SEB, and TSST1 [<xref rid="B86-pathogens-10-00091" ref-type="bibr">86</xref>]. </p><p>Besides, several compounds block biofilm formation or bacterial adhesion to host tissues that are important to reduce the virulence of <italic>S. aureus</italic>. For instance, the hop plant (<italic>Humulus lupulus</italic>) contains xanthohumol, which showed significant antimicrobial activity against <italic>S. aureus</italic> and inhibited its biofilm formation [<xref rid="B87-pathogens-10-00091" ref-type="bibr">87</xref>]. Moreover, allylisothiocyanate is the product responsible for the pungent taste of mustard, radish, or wasabi, and it is an efficient biofilm inhibitor of many different bacteria, including <italic>S. aureus</italic> [<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>,<xref rid="B88-pathogens-10-00091" ref-type="bibr">88</xref>]. There are many more antibiofilm compounds produced by plants, including terpenes, flavonoids, and other phenolic compounds, with variable effectiveness [<xref rid="B35-pathogens-10-00091" ref-type="bibr">35</xref>,<xref rid="B101-pathogens-10-00091" ref-type="bibr">101</xref>].</p><p>Other plant-derived compounds may exhibit broad anti-staphylococcal activities. For instance, aloeemodin is an inhibitor of the Accessory Gene Regulation C (AgrC) produced by aloe vera, which strongly impacts <italic>S. aureus</italic> because the AgrCA two-component system controls the expression of many virulence factors [<xref rid="B64-pathogens-10-00091" ref-type="bibr">64</xref>]. On the other hand, eucalyptus and mimosa plants produce pyroligneous acid (PA) with antiseptic activities that have been tested against several bacterial pathogens, including <italic>S. aureus</italic> [<xref rid="B89-pathogens-10-00091" ref-type="bibr">89</xref>,<xref rid="B102-pathogens-10-00091" ref-type="bibr">102</xref>]. </p><p>Fungi are another very rich source of antimicrobial compounds that include terpenes, anthraquinones, quinolines, or benzoic acid derivatives (<xref rid="pathogens-10-00091-t001" ref-type="table">Table 1</xref>). For example, members of the genus <italic>Ganoderma</italic> produce many antimicrobial compounds that have been tested against <italic>S. aureus</italic> [<xref rid="B90-pathogens-10-00091" ref-type="bibr">90</xref>,<xref rid="B103-pathogens-10-00091" ref-type="bibr">103</xref>]. However, the lack of knowledge on the mechanism of action of these compounds is still impeding their application in the food industry. </p><p>Other European-distributed fungi such as <italic>Caloboletus radicans</italic> produce the anti-staphylococcal compounds 8-deacetylcyclocalopin [<xref rid="B90-pathogens-10-00091" ref-type="bibr">90</xref>]. In addition, <italic>Pleurotus sajor-caju</italic> produces acid compounds with anti-staphylococcal activity, such as <italic>p</italic>-hydroxybenzoic, <italic>p</italic>-coumaric, and cinnamic acids [<xref rid="B90-pathogens-10-00091" ref-type="bibr">90</xref>,<xref rid="B91-pathogens-10-00091" ref-type="bibr">91</xref>]. </p><p>Honey is another well-studied natural product with antimicrobial activity [<xref rid="B104-pathogens-10-00091" ref-type="bibr">104</xref>]. Honey is composed mainly of sugars, but many other compounds are part of this natural product (<xref rid="pathogens-10-00091-t001" ref-type="table">Table 1</xref>). Firstly, its physiological characteristics, such as its acidity and low water activity, make it a challenging substrate for bacterial growth [<xref rid="B92-pathogens-10-00091" ref-type="bibr">92</xref>]. However, the complexity of honey composition and its components&#x02019; heterogeneity makes it difficult to compare and find the most active compounds with the highest antimicrobial potential [<xref rid="B93-pathogens-10-00091" ref-type="bibr">93</xref>]. Furthermore, the enzymatic conversion of glucose results in various compounds with antibacterial properties, such as hydrogen peroxide and gluconic acid, which show dose-dependent bactericidal effects [<xref rid="B92-pathogens-10-00091" ref-type="bibr">92</xref>,<xref rid="B93-pathogens-10-00091" ref-type="bibr">93</xref>,<xref rid="B94-pathogens-10-00091" ref-type="bibr">94</xref>,<xref rid="B95-pathogens-10-00091" ref-type="bibr">95</xref>]. </p><p>Polyphenols are also key antimicrobial molecules present in honey, despite that the polyphenolic profile and its bioactivity changes significantly between many different types of honey [<xref rid="B92-pathogens-10-00091" ref-type="bibr">92</xref>,<xref rid="B105-pathogens-10-00091" ref-type="bibr">105</xref>]. Interestingly, the floral source of the honey seems to be a key factor influencing its composition of polyphenolic compounds and their antibacterial activity [<xref rid="B106-pathogens-10-00091" ref-type="bibr">106</xref>,<xref rid="B107-pathogens-10-00091" ref-type="bibr">107</xref>]. </p><p>Wax propolis is another bee-derived product made basically of resins, waxes, polyphenols, polysaccharides, volatile materials, and secondary metabolites that show antibacterial, antioxidant, or antiviral activities [<xref rid="B96-pathogens-10-00091" ref-type="bibr">96</xref>]. Different propolis types have shown activity against different Gram-positive and Gram-negative bacteria, including <italic>S. aureus</italic> [<xref rid="B97-pathogens-10-00091" ref-type="bibr">97</xref>]. Similar to honey, the floral origin of the propolis determines its composition and antimicrobial activity.</p><p>Finally, many natural products inhibit the AgrC-based quorum sensing, biofilm formation, and cell-to-cell communication in <italic>S. aureus</italic> [<xref rid="B64-pathogens-10-00091" ref-type="bibr">64</xref>,<xref rid="B65-pathogens-10-00091" ref-type="bibr">65</xref>,<xref rid="B108-pathogens-10-00091" ref-type="bibr">108</xref>,<xref rid="B109-pathogens-10-00091" ref-type="bibr">109</xref>]. These compounds are frequently produced by fungi or plants and include cinnamaldehyde, baicalein, apicidin, &#x003b1;-cyperone, or avellanin C [<xref rid="B64-pathogens-10-00091" ref-type="bibr">64</xref>,<xref rid="B98-pathogens-10-00091" ref-type="bibr">98</xref>,<xref rid="B99-pathogens-10-00091" ref-type="bibr">99</xref>]. In addition, some bacteria with probiotic potential, such as <italic>Bacillus</italic> spp., may also produce very effective quorum-sensing inhibitors [<xref rid="B110-pathogens-10-00091" ref-type="bibr">110</xref>]. </p></sec></sec><sec sec-type="conclusions" id="sec4-pathogens-10-00091"><title>4. Conclusions</title><p>The incidence of antimicrobial-resistant bacterial infections is increasing worldwide, and the development of new antimicrobial therapies is not keeping pace with the acquisition and transmission of antibacterial resistance. <italic>S. aureus</italic> is one of the most important human pathogens, and it is quickly acquiring resistance to last-resort drugs used in clinical medicine. Moreover, staphylococci and their exotoxins are important sources of food contamination. There are many promising preventative and therapeutic strategies against staphylococcal food intoxications, but very few have been tested in vivo, and a limited number of clinical trials have been conducted with these compounds. </p><p>One of these exceptions is the flavonoid naringenin, which has been recently tested in clinical trials [<xref rid="B111-pathogens-10-00091" ref-type="bibr">111</xref>]. However, naringenin has a low oral bioavailability; thus, new naringenin-glycosylated derivatives are currently developed to improve its absorption profile. Many other natural compounds with antimicrobial activity against staphylococci have only been tested in preclinical trials due to their low absorption, distribution, metabolism, or excretion properties. </p><p>Nevertheless, the natural products with antimicrobial activity against staphylococci have the potential to be used as food additives alone or in combination to prevent food-poisonings. However, more research is required to test the dosage and stability of the compounds with the best antimicrobial profiles. </p><p>Plant-derived polyphenols are one of the most important sources of antimicrobial compounds with activity against <italic>S. aureus</italic>. Flavonoids, terpenoids, and other important antimicrobial compounds could be found in citrus fruits, grapes, honey, garlic, and other inexpensive food that undoubtedly may impact the incidence of staphylococcal food intoxications and the spread of antimicrobial resistance. Combining different natural compounds could enhance their antimicrobial or antitoxin activities, but more research is needed to evaluate their possible synergistic effects.</p></sec></body><back><ack><title>Acknowledgments</title><p>We are thankful to the anonymous reviewers for reading our manuscript and their insightful comments and suggestions.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>&#x000c1;.M. wrote the first draft of the manuscript. &#x000c1;.M., J.A.G., L.M.M., and M.L. contributed to manuscript edition, revision, read, and approved the submitted version. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>We want to thank the Junta de Castilla y Le&#x000f3;n (Spain) for funding our research work (Ref. LE044P20).</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-pathogens-10-00091"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hennekinne</surname><given-names>J.A.</given-names></name><name><surname>De Buyser</surname><given-names>M.L.</given-names></name><name><surname>Dragacci</surname><given-names>S.</given-names></name></person-group><article-title><italic>Staphylococcus aureus</italic> and its food poisoning toxins: Characterization and outbreak investigation</article-title><source>FEMS Microbiol. Rev.</source><year>2012</year><volume>36</volume><fpage>815</fpage><lpage>836</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2011.00311.x</pub-id><pub-id pub-id-type="pmid">22091892</pub-id></element-citation></ref><ref id="B2-pathogens-10-00091"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaj&#x00119;cka-Wierzchowska</surname><given-names>W.</given-names></name><name><surname>Gajewska</surname><given-names>J.</given-names></name><name><surname>Wi&#x0015b;niewski</surname><given-names>P.</given-names></name><name><surname>Zadernowska</surname><given-names>A.</given-names></name></person-group><article-title>Enterotoxigenic potential of coagulase-negative staphylococci from ready-to-eat food</article-title><source>Pathogens</source><year>2020</year><volume>9</volume><elocation-id>734</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens9090734</pub-id><?supplied-pmid 32899905?><pub-id pub-id-type="pmid">32899905</pub-id></element-citation></ref><ref id="B3-pathogens-10-00091"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyra</surname><given-names>D.G.</given-names></name><name><surname>Sousa</surname><given-names>F.G.C.</given-names></name><name><surname>Borges</surname><given-names>M.F.</given-names></name><name><surname>Givisiez</surname><given-names>P.E.N.</given-names></name><name><surname>Queiroga</surname><given-names>R.C.R.E.</given-names></name><name><surname>Souza</surname><given-names>E.L.</given-names></name><name><surname>Gebreyes</surname><given-names>W.A.</given-names></name><name><surname>Oliveira</surname><given-names>C.J.B.</given-names></name></person-group><article-title>Enterotoxin-encoding genes in <italic>Staphylococcus</italic> spp. from bulk goat milk</article-title><source>Foodborne Pathog. Dis.</source><year>2013</year><volume>10</volume><fpage>126</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1089/fpd.2012.1256</pub-id><pub-id pub-id-type="pmid">23441914</pub-id></element-citation></ref><ref id="B4-pathogens-10-00091"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Andrade</surname><given-names>A.P.C.</given-names></name><name><surname>De F&#x000e1;timaborges</surname><given-names>M.</given-names></name><name><surname>de Figueiredo</surname><given-names>E.A.T.</given-names></name><name><surname>Arcuri</surname><given-names>E.F.</given-names></name></person-group><article-title>Diversity of <italic>Staphylococcus</italic> coagulase-positive and negative strains of coalho cheese and detection of enterotoxin encoding genes</article-title><source>Embrapa Agroind&#x000fa;stria Trop. Artig. Peri&#x000f3;dico Indexado</source><year>2019</year><volume>36</volume><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="B5-pathogens-10-00091"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubert</surname><given-names>J.</given-names></name><name><surname>Podkowik</surname><given-names>M.</given-names></name><name><surname>Bystro&#x00144;</surname><given-names>J.</given-names></name><name><surname>Bania</surname><given-names>J.</given-names></name></person-group><article-title>Production of staphylococcal enterotoxins in microbial broth and milk by <italic>Staphylococcus aureus</italic> strains harboring <italic>seh</italic> gene</article-title><source>Int. J. Food Microbiol.</source><year>2016</year><volume>235</volume><fpage>36</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2016.06.043</pub-id><?supplied-pmid 27400451?><pub-id pub-id-type="pmid">27400451</pub-id></element-citation></ref><ref id="B6-pathogens-10-00091"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewida</surname><given-names>R.M.</given-names></name><name><surname>Al-Hosary</surname><given-names>A.A.T.</given-names></name></person-group><article-title>Prevalence of enterotoxins and other virulence genes of <italic>Staphylococcus aureus</italic> caused subclinical mastitis in dairy cows</article-title><source>Vet. World</source><year>2020</year><volume>13</volume><fpage>1193</fpage><lpage>1198</lpage><pub-id pub-id-type="doi">10.14202/vetworld.2020.1193-1198</pub-id><pub-id pub-id-type="pmid">32801573</pub-id></element-citation></ref><ref id="B7-pathogens-10-00091"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Loir</surname><given-names>Y.</given-names></name><name><surname>Baron</surname><given-names>F.</given-names></name><name><surname>Gautier</surname><given-names>M.</given-names></name></person-group><article-title><italic>Staphylococcus aureus</italic> and food poisoning</article-title><source>Genet. Mol. Res.</source><year>2003</year><volume>2</volume><fpage>63</fpage><lpage>76</lpage><?supplied-pmid 12917803?><pub-id pub-id-type="pmid">12917803</pub-id></element-citation></ref><ref id="B8-pathogens-10-00091"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinchuk</surname><given-names>I.V.</given-names></name><name><surname>Beswick</surname><given-names>E.J.</given-names></name><name><surname>Reyes</surname><given-names>V.E.</given-names></name></person-group><article-title>Staphylococcal enterotoxins</article-title><source>Toxins</source><year>2010</year><volume>2</volume><fpage>2177</fpage><lpage>2197</lpage><pub-id pub-id-type="doi">10.3390/toxins2082177</pub-id><pub-id pub-id-type="pmid">22069679</pub-id></element-citation></ref><ref id="B9-pathogens-10-00091"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grispoldi</surname><given-names>L.</given-names></name><name><surname>Popescu</surname><given-names>P.A.</given-names></name><name><surname>Karama</surname><given-names>M.</given-names></name><name><surname>Gullo</surname><given-names>V.</given-names></name><name><surname>Poerio</surname><given-names>G.</given-names></name><name><surname>Borgogni</surname><given-names>E.</given-names></name><name><surname>Torlai</surname><given-names>P.</given-names></name><name><surname>Chianese</surname><given-names>G.</given-names></name><name><surname>Fermani</surname><given-names>A.G.</given-names></name><name><surname>Sechi</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Study on the growth and enterotoxin production by <italic>Staphylococcus aureus</italic> in canned meat before retorting</article-title><source>Toxins</source><year>2019</year><volume>11</volume><elocation-id>291</elocation-id><pub-id pub-id-type="doi">10.3390/toxins11050291</pub-id></element-citation></ref><ref id="B10-pathogens-10-00091"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Ono</surname><given-names>H.K.</given-names></name><name><surname>Shimojima</surname><given-names>Y.</given-names></name><name><surname>Kubota</surname><given-names>H.</given-names></name><name><surname>Kato</surname><given-names>R.</given-names></name><name><surname>Kakuda</surname><given-names>T.</given-names></name><name><surname>Hirose</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>D.L.</given-names></name><name><surname>Nakane</surname><given-names>A.</given-names></name><name><surname>Takai</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A novel staphylococcal enterotoxin SE02 involved in a staphylococcal food poisoning outbreak that occurred in Tokyo in 2004</article-title><source>Food Microbiol.</source><year>2020</year><volume>92</volume><fpage>103588</fpage><pub-id pub-id-type="doi">10.1016/j.fm.2020.103588</pub-id><pub-id pub-id-type="pmid">32950172</pub-id></element-citation></ref><ref id="B11-pathogens-10-00091"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>A.</given-names></name><name><surname>Santos</surname><given-names>C.</given-names></name><name><surname>Meireles</surname><given-names>H.</given-names></name><name><surname>Silva</surname><given-names>J.</given-names></name><name><surname>Teixeira</surname><given-names>P.</given-names></name></person-group><article-title>Food handlers as potential sources of dissemination of virulent strains of <italic>Staphylococcus aureus</italic> in the community</article-title><source>J. Infect. Public Health</source><year>2016</year><volume>9</volume><fpage>153</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.jiph.2015.08.001</pub-id><pub-id pub-id-type="pmid">26424093</pub-id></element-citation></ref><ref id="B12-pathogens-10-00091"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Tang</surname><given-names>T.</given-names></name><name><surname>Stegger</surname><given-names>M.</given-names></name><name><surname>Dalsgaard</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Leisner</surname><given-names>J.J.</given-names></name></person-group><article-title>Characterization of antimicrobial-resistant <italic>Staphylococcus aureus</italic> from retail foods in Beijing, China</article-title><source>Food Microbiol.</source><year>2021</year><volume>93</volume><fpage>103603</fpage><pub-id pub-id-type="doi">10.1016/j.fm.2020.103603</pub-id><?supplied-pmid 32912578?><pub-id pub-id-type="pmid">32912578</pub-id></element-citation></ref><ref id="B13-pathogens-10-00091"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mama</surname><given-names>O.M.</given-names></name><name><surname>G&#x000f3;mez-Sanz</surname><given-names>E.</given-names></name><name><surname>Ruiz-Ripa</surname><given-names>L.</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>P.</given-names></name><name><surname>Torres</surname><given-names>C.</given-names></name></person-group><article-title>Diversity of staphylococcal species in food producing animals in Spain, with detection of PVL-positive MRSA ST8 (USA300)</article-title><source>Vet. Microbiol.</source><year>2019</year><volume>233</volume><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2019.04.013</pub-id><?supplied-pmid 31176412?><pub-id pub-id-type="pmid">31176412</pub-id></element-citation></ref><ref id="B14-pathogens-10-00091"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>Y.C.</given-names></name><name><surname>Liao</surname><given-names>W.W.</given-names></name><name><surname>Fan</surname><given-names>C.M.</given-names></name><name><surname>Pai</surname><given-names>W.Y.</given-names></name><name><surname>Chiou</surname><given-names>C.S.</given-names></name><name><surname>Tsen</surname><given-names>H.Y.</given-names></name></person-group><article-title>PCR detection of Staphylococcal enterotoxins (SEs) N, O, P, Q, R, U, and survey of SE types in <italic>Staphylococcus aureus</italic> isolates from food-poisoning cases in Taiwan</article-title><source>Int. J. Food Microbiol.</source><year>2008</year><volume>121</volume><fpage>66</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2007.10.005</pub-id><?supplied-pmid 18068843?><pub-id pub-id-type="pmid">18068843</pub-id></element-citation></ref><ref id="B15-pathogens-10-00091"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schelin</surname><given-names>J.</given-names></name><name><surname>Susilo</surname><given-names>Y.B.</given-names></name><name><surname>Johler</surname><given-names>S.</given-names></name></person-group><article-title>Expression of staphylococcal enterotoxins under stress encountered during food production and preservation</article-title><source>Toxins</source><year>2017</year><volume>9</volume><elocation-id>401</elocation-id><pub-id pub-id-type="doi">10.3390/toxins9120401</pub-id><?supplied-pmid 29244757?><pub-id pub-id-type="pmid">29244757</pub-id></element-citation></ref><ref id="B16-pathogens-10-00091"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>G.O.</given-names></name><name><surname>Castro</surname><given-names>R.D.</given-names></name><name><surname>Oliveira</surname><given-names>L.G.</given-names></name><name><surname>Sant&#x02019;Anna</surname><given-names>F.M.</given-names></name><name><surname>Barbosa</surname><given-names>C.D.</given-names></name><name><surname>Sandes</surname><given-names>S.H.C.</given-names></name><name><surname>Silva</surname><given-names>R.S.</given-names></name><name><surname>Resende</surname><given-names>M.F.S.</given-names></name><name><surname>Lana</surname><given-names>A.M.Q.</given-names></name><name><surname>Nunes</surname><given-names>A.C.</given-names></name><etal/></person-group><article-title>Viability of <italic>Staphylococcus aureus</italic> and expression of its toxins (SEC and TSST-1) in cheeses using <italic>Lactobacillus rhamnosus</italic> D1 or <italic>Weissella paramesenteroides</italic> GIR16L4 or both as starter cultures</article-title><source>J. Dairy Sci.</source><year>2020</year><volume>103</volume><fpage>4100</fpage><lpage>4108</lpage><pub-id pub-id-type="doi">10.3168/jds.2018-16037</pub-id><pub-id pub-id-type="pmid">32197850</pub-id></element-citation></ref><ref id="B17-pathogens-10-00091"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasaj</surname><given-names>M.</given-names></name><name><surname>Saeidi</surname><given-names>Z.</given-names></name><name><surname>Tahmasebi</surname><given-names>H.</given-names></name><name><surname>Dehbashi</surname><given-names>S.</given-names></name><name><surname>Arabestani</surname><given-names>M.</given-names></name></person-group><article-title>Prevalence and Distribution of Resistance and Enterotoxins/Enterotoxin-likes Genes in Different Clinical Isolates of Coagulase-negative <italic>Staphylococcus</italic></article-title><source>Eur. J. Med. Res.</source><year>2020</year><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/s40001-020-00447-w</pub-id><pub-id pub-id-type="pmid">31901238</pub-id></element-citation></ref><ref id="B18-pathogens-10-00091"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do Carmo</surname><given-names>L.S.</given-names></name><name><surname>Dias</surname><given-names>R.S.</given-names></name><name><surname>Linardi</surname><given-names>V.R.</given-names></name><name><surname>De Sena</surname><given-names>M.J.</given-names></name><name><surname>Dos Santos</surname><given-names>D.A.</given-names></name><name><surname>De Faria</surname><given-names>M.E.</given-names></name><name><surname>Pena</surname><given-names>E.C.</given-names></name><name><surname>Jett</surname><given-names>M.</given-names></name><name><surname>Heneine</surname><given-names>L.G.</given-names></name></person-group><article-title>Food poisoning due to enterotoxigenic strains of <italic>Staphylococcus</italic> present in Minas cheese and raw milk in Brazil</article-title><source>Food Microbiol.</source><year>2002</year><volume>19</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1006/fmic.2001.0444</pub-id></element-citation></ref><ref id="B19-pathogens-10-00091"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loncaric</surname><given-names>I.</given-names></name><name><surname>K&#x000fc;bber-heiss</surname><given-names>A.</given-names></name><name><surname>Posautz</surname><given-names>A.</given-names></name><name><surname>Ruppitsch</surname><given-names>W.</given-names></name><name><surname>Lepuschitz</surname><given-names>S.</given-names></name><name><surname>Schauer</surname><given-names>B.</given-names></name><name><surname>Fe&#x000df;ler</surname><given-names>A.T.</given-names></name><name><surname>Krametter-fr&#x000f6;tscher</surname><given-names>R.</given-names></name><name><surname>Harrison</surname><given-names>E.M.</given-names></name><name><surname>Holmes</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>Characterization of <italic>mecC</italic> gene-carrying coagulase-negative <italic>Staphylococcus</italic> spp. isolated from various animals</article-title><source>Vet. Microbiol.</source><year>2019</year><volume>230</volume><fpage>138</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2019.02.014</pub-id><pub-id pub-id-type="pmid">30827379</pub-id></element-citation></ref><ref id="B20-pathogens-10-00091"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>D.O.</given-names></name><name><surname>Loeffler</surname><given-names>A.</given-names></name><name><surname>Davis</surname><given-names>M.F.</given-names></name><name><surname>Guardabassi</surname><given-names>L.</given-names></name><name><surname>Weese</surname><given-names>J.S.</given-names></name></person-group><article-title>Recommendations for approaches to meticillin-resistant staphylococcal infections of small animals: Diagnosis, therapeutic considerations and preventative measures.: Clinical Consensus Guidelines of the World Association for Veterinary Dermatology</article-title><source>Vet. Dermatol.</source><year>2017</year><volume>28</volume><pub-id pub-id-type="doi">10.1111/vde.12444</pub-id></element-citation></ref><ref id="B21-pathogens-10-00091"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bora</surname><given-names>P.</given-names></name><name><surname>Datta</surname><given-names>P.</given-names></name><name><surname>Gupta</surname><given-names>V.</given-names></name><name><surname>Singhal</surname><given-names>L.</given-names></name><name><surname>Chander</surname><given-names>J.</given-names></name></person-group><article-title>Characterization and antimicrobial susceptibility of coagulase-negative staphylococci isolated from clinical samples</article-title><source>J. Lab. Physicians</source><year>2018</year><volume>10</volume><fpage>414</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.4103/JLP.JLP_55_18</pub-id><?supplied-pmid 30498314?><pub-id pub-id-type="pmid">30498314</pub-id></element-citation></ref><ref id="B22-pathogens-10-00091"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaulding</surname><given-names>A.R.</given-names></name><name><surname>Salgado-Pab&#x000f3;n</surname><given-names>W.</given-names></name><name><surname>Kohler</surname><given-names>P.L.</given-names></name><name><surname>Horswill</surname><given-names>A.R.</given-names></name><name><surname>Leung</surname><given-names>D.Y.M.</given-names></name><name><surname>Schlievert</surname><given-names>P.M.</given-names></name></person-group><article-title>Staphylococcal and streptococcal superantigen exotoxins</article-title><source>Clin. Microbiol. Rev.</source><year>2013</year><volume>26</volume><fpage>422</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1128/CMR.00104-12</pub-id><?supplied-pmid 23824366?><pub-id pub-id-type="pmid">23824366</pub-id></element-citation></ref><ref id="B23-pathogens-10-00091"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachert</surname><given-names>C.</given-names></name><name><surname>Gevaert</surname><given-names>P.</given-names></name><name><surname>van Cauwenberge</surname><given-names>P.</given-names></name></person-group><article-title><italic>Staphylococcus aureus</italic> superantigens and airway disease</article-title><source>Curr. Allergy Asthma Rep.</source><year>2002</year><volume>2</volume><fpage>252</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1007/s11882-002-0027-9</pub-id><?supplied-pmid 11918868?><pub-id pub-id-type="pmid">11918868</pub-id></element-citation></ref><ref id="B24-pathogens-10-00091"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krakauer</surname><given-names>T.</given-names></name></person-group><article-title>Staphylococcal superantigens: Pyrogenic toxins induce toxic shock</article-title><source>Toxins</source><year>2019</year><volume>11</volume><elocation-id>178</elocation-id><pub-id pub-id-type="doi">10.3390/toxins11030178</pub-id><?supplied-pmid 30909619?><pub-id pub-id-type="pmid">30909619</pub-id></element-citation></ref><ref id="B25-pathogens-10-00091"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aman</surname><given-names>M.J.</given-names></name></person-group><article-title>Superantigens of a superbug: Major culprits of <italic>Staphylococcus aureus</italic> disease?</article-title><source>Virulence</source><year>2017</year><volume>8</volume><fpage>607</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1080/21505594.2016.1255399</pub-id><pub-id pub-id-type="pmid">27805458</pub-id></element-citation></ref><ref id="B26-pathogens-10-00091"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krakauer</surname><given-names>T.</given-names></name><name><surname>Stiles</surname><given-names>B.G.</given-names></name></person-group><article-title>The staphylococcal enterotoxin (SE) family: SEB and siblings</article-title><source>Virulence</source><year>2013</year><volume>4</volume><fpage>759</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.4161/viru.23905</pub-id><pub-id pub-id-type="pmid">23959032</pub-id></element-citation></ref><ref id="B27-pathogens-10-00091"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Rao</surname><given-names>X.</given-names></name></person-group><article-title>Apoptosis induced by <italic>Staphylococcus aureus</italic> toxins</article-title><source>Microbiol. Res.</source><year>2017</year><volume>205</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2017.08.006</pub-id><pub-id pub-id-type="pmid">28942840</pub-id></element-citation></ref><ref id="B28-pathogens-10-00091"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salgado-Pab&#x000f3;n</surname><given-names>W.</given-names></name><name><surname>Breshears</surname><given-names>L.</given-names></name><name><surname>Spaulding</surname><given-names>A.R.</given-names></name><name><surname>Merriman</surname><given-names>J.A.</given-names></name><name><surname>Stach</surname><given-names>C.S.</given-names></name><name><surname>Horswill</surname><given-names>A.R.</given-names></name><name><surname>Peterson</surname><given-names>M.L.</given-names></name><name><surname>Schlievert</surname><given-names>P.M.</given-names></name></person-group><article-title>Superantigens are critical for <italic>Staphylococcus aureus</italic> infective endocarditis, sepsis, and acute kidney injury</article-title><source>MBio</source><year>2013</year><volume>4</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1128/mBio.00494-13</pub-id></element-citation></ref><ref id="B29-pathogens-10-00091"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benkerroum</surname><given-names>N.</given-names></name></person-group><article-title>Staphylococcal enterotoxins and enterotoxin-like toxins with special reference to dairy products: An overview</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2018</year><volume>58</volume><fpage>1943</fpage><lpage>1970</lpage><pub-id pub-id-type="doi">10.1080/10408398.2017.1289149</pub-id><pub-id pub-id-type="pmid">28362113</pub-id></element-citation></ref><ref id="B30-pathogens-10-00091"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strandberg</surname><given-names>K.L.</given-names></name><name><surname>Rotschafer</surname><given-names>J.H.</given-names></name><name><surname>Vetter</surname><given-names>S.M.</given-names></name><name><surname>Buonpane</surname><given-names>R.A.</given-names></name><name><surname>Kranz</surname><given-names>D.M.</given-names></name><name><surname>Schlievert</surname><given-names>P.M.</given-names></name></person-group><article-title>Staphylococcal superantigens cause lethal pulmonary disease in rabbits</article-title><source>J. Infect. Dis.</source><year>2010</year><volume>202</volume><fpage>1690</fpage><lpage>1697</lpage><pub-id pub-id-type="doi">10.1086/657156</pub-id><pub-id pub-id-type="pmid">20979456</pub-id></element-citation></ref><ref id="B31-pathogens-10-00091"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adame-G&#x000f3;mez</surname><given-names>R.</given-names></name><name><surname>Castro-Alarc&#x000f3;n</surname><given-names>N.</given-names></name><name><surname>Vences-Vel&#x000e1;zquez</surname><given-names>A.</given-names></name><name><surname>Toribio-Jim&#x000e9;nez</surname><given-names>J.</given-names></name><name><surname>P&#x000e9;rez-Valdespino</surname><given-names>A.</given-names></name><name><surname>Leyva-V&#x000e1;zquez</surname><given-names>M.A.</given-names></name><name><surname>Ram&#x000ed;rez-Peralta</surname><given-names>A.</given-names></name></person-group><article-title>Genetic Diversity and Virulence Factors of <italic>S. aureus</italic> Isolated from Food, Humans, and Animals</article-title><source>Int. J. Microbiol.</source><year>2020</year><volume>2020</volume><pub-id pub-id-type="doi">10.1155/2020/1048097</pub-id><?supplied-pmid 32908519?><pub-id pub-id-type="pmid">32908519</pub-id></element-citation></ref><ref id="B32-pathogens-10-00091"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughn</surname><given-names>J.M.</given-names></name><name><surname>Abdi</surname><given-names>R.D.</given-names></name><name><surname>Gillespie</surname><given-names>B.E.</given-names></name><name><surname>Dego</surname><given-names>O.K.</given-names></name></person-group><article-title>Genetic diversity and virulence characteristics of <italic>Staphylococcus aureus</italic> isolates from cases of bovine mastitis</article-title><source>Microb. Pathog.</source><year>2020</year><volume>144</volume><fpage>104171</fpage><pub-id pub-id-type="doi">10.1016/j.micpath.2020.104171</pub-id><?supplied-pmid 32224210?><pub-id pub-id-type="pmid">32224210</pub-id></element-citation></ref><ref id="B33-pathogens-10-00091"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shettigar</surname><given-names>K.</given-names></name><name><surname>Murali</surname><given-names>T.S.</given-names></name></person-group><article-title>Virulence factors and clonal diversity of <italic>Staphylococcus aureus</italic> in colonization and wound infection with emphasis on diabetic foot infection</article-title><source>Eur. J. Clin. Microbiol. Infect. Dis.</source><year>2020</year><volume>39</volume><fpage>2235</fpage><lpage>2246</lpage><pub-id pub-id-type="doi">10.1007/s10096-020-03984-8</pub-id><?supplied-pmid 32683595?><pub-id pub-id-type="pmid">32683595</pub-id></element-citation></ref><ref id="B34-pathogens-10-00091"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horn</surname><given-names>J.</given-names></name><name><surname>Klepsch</surname><given-names>M.</given-names></name><name><surname>Manger</surname><given-names>M.</given-names></name><name><surname>Wolz</surname><given-names>C.</given-names></name><name><surname>Rudel</surname><given-names>T.</given-names></name><name><surname>Fraunholz</surname><given-names>M.</given-names></name></person-group><article-title>Long noncoding RNA SSR42 controls <italic>Staphylococcus aureus</italic> alpha-toxin transcription in response to environmental stimuli</article-title><source>J. Bacteriol.</source><year>2018</year><volume>200</volume><fpage>e00252-18</fpage><pub-id pub-id-type="doi">10.1128/JB.00252-18</pub-id><?supplied-pmid 30150231?><pub-id pub-id-type="pmid">30150231</pub-id></element-citation></ref><ref id="B35-pathogens-10-00091"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>L.N.</given-names></name><name><surname>Zimmer</surname><given-names>K.R.</given-names></name><name><surname>Macedo</surname><given-names>A.J.</given-names></name><name><surname>Trentin</surname><given-names>D.S.</given-names></name></person-group><article-title>Plant natural products targeting bacterial virulence factors</article-title><source>Chem. Rev.</source><year>2016</year><volume>116</volume><fpage>9162</fpage><lpage>9236</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00184</pub-id><pub-id pub-id-type="pmid">27437994</pub-id></element-citation></ref><ref id="B36-pathogens-10-00091"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>W.T.</given-names></name><name><surname>Balsa</surname><given-names>D.</given-names></name><name><surname>Espinosa</surname><given-names>M.</given-names></name></person-group><article-title>One cannot rule them all: Are bacterial toxins-antitoxins druggable?</article-title><source>FEMS Microbiol. Rev.</source><year>2015</year><volume>39</volume><fpage>522</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1093/femsre/fuv002</pub-id><pub-id pub-id-type="pmid">25796610</pub-id></element-citation></ref><ref id="B37-pathogens-10-00091"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>J.J.</given-names></name><name><surname>Hergenrother</surname><given-names>P.J.</given-names></name></person-group><article-title>Artificial activation of toxin-antitoxin systems as an antibacterial strategy</article-title><source>Trends Microbiol.</source><year>2012</year><volume>20</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2012.02.005</pub-id><pub-id pub-id-type="pmid">22445361</pub-id></element-citation></ref><ref id="B38-pathogens-10-00091"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sergelidis</surname><given-names>D.</given-names></name><name><surname>Angelidis</surname><given-names>A.S.</given-names></name></person-group><article-title>Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: Analysis of results obtained in the DULCIS study</article-title><source>Lett. Appl. Microbiol.</source><year>2017</year><volume>64</volume><fpage>409</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1111/lam.12735</pub-id><pub-id pub-id-type="pmid">28304109</pub-id></element-citation></ref><ref id="B39-pathogens-10-00091"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasigade</surname><given-names>J.P.</given-names></name></person-group><article-title>Catching the evader: Can monoclonal antibodies interfere with <italic>Staphylococcus aureus</italic> immune escape?</article-title><source>Virulence</source><year>2018</year><volume>9</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1080/21505594.2017.1320012</pub-id><pub-id pub-id-type="pmid">28441093</pub-id></element-citation></ref><ref id="B40-pathogens-10-00091"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pier</surname><given-names>G.B.</given-names></name></person-group><article-title>Will there ever be a universal <italic>Staphylococcus aureus</italic> vaccine?</article-title><source>Hum. Vaccines Immunother.</source><year>2013</year><volume>9</volume><fpage>1865</fpage><lpage>1876</lpage><pub-id pub-id-type="doi">10.4161/hv.25182</pub-id></element-citation></ref><ref id="B41-pathogens-10-00091"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname><given-names>V.G.</given-names></name><name><surname>Proctor</surname><given-names>R.A.</given-names></name></person-group><article-title>Where does a <italic>Staphylococcus aureus</italic> vaccine stand?</article-title><source>Clin. Microbiol. Infect.</source><year>2014</year><volume>20</volume><fpage>66</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1111/1469-0691.12570</pub-id><?supplied-pmid 24476315?><pub-id pub-id-type="pmid">24476315</pub-id></element-citation></ref><ref id="B42-pathogens-10-00091"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>L.S.</given-names></name><name><surname>Fowler</surname><given-names>V.G.</given-names></name><name><surname>Shukla</surname><given-names>S.K.</given-names></name><name><surname>Rose</surname><given-names>W.E.</given-names></name><name><surname>Proctor</surname><given-names>R.A.</given-names></name></person-group><article-title>Development of a vaccine against <italic>Staphylococcus aureus</italic> invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms</article-title><source>FEMS Microbiol Rev.</source><year>2020</year><volume>44</volume><fpage>123</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1093/femsre/fuz030</pub-id><?supplied-pmid 31841134?><pub-id pub-id-type="pmid">31841134</pub-id></element-citation></ref><ref id="B43-pathogens-10-00091"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adhikari</surname><given-names>R.P.</given-names></name><name><surname>Ajao</surname><given-names>A.O.</given-names></name><name><surname>Aman</surname><given-names>M.J.</given-names></name><name><surname>Karauzum</surname><given-names>H.</given-names></name><name><surname>Sarwar</surname><given-names>J.</given-names></name><name><surname>Lydecker</surname><given-names>A.D.</given-names></name><name><surname>Johnson</surname><given-names>J.K.</given-names></name><name><surname>Nguyen</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>W.H.</given-names></name><name><surname>Roghmann</surname><given-names>M.C.</given-names></name></person-group><article-title>Lower antibody levels to <italic>Staphylococcus aureus</italic> exotoxins are associated with sepsis in hospitalized adults with invasive <italic>S. aureus</italic> infections</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>206</volume><fpage>915</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis462</pub-id><?supplied-pmid 22807524?><pub-id pub-id-type="pmid">22807524</pub-id></element-citation></ref><ref id="B44-pathogens-10-00091"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>M.</given-names></name></person-group><article-title><italic>Staphylococcus</italic> colonization of the skin and antimicrobial peptides</article-title><source>Expert Rev Dermatol.</source><year>2010</year><volume>5</volume><fpage>183</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1586/edm.10.6</pub-id><pub-id pub-id-type="pmid">20473345</pub-id></element-citation></ref><ref id="B45-pathogens-10-00091"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zurawski</surname><given-names>D.V.</given-names></name><name><surname>McLendon</surname><given-names>M.K.</given-names></name></person-group><article-title>Monoclonal antibodies as an antibacterial approach against bacterial pathogens</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>155</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9040155</pub-id><?supplied-pmid 32244733?><pub-id pub-id-type="pmid">32244733</pub-id></element-citation></ref><ref id="B46-pathogens-10-00091"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luciani</surname><given-names>M.</given-names></name><name><surname>Iannetti</surname><given-names>L.</given-names></name></person-group><article-title>Monoclonal antibodies and bacterial virulence</article-title><source>Virulence</source><year>2017</year><volume>8</volume><fpage>635</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1080/21505594.2017.1292199</pub-id><pub-id pub-id-type="pmid">28276995</pub-id></element-citation></ref><ref id="B47-pathogens-10-00091"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raafat</surname><given-names>D.</given-names></name><name><surname>Otto</surname><given-names>M.</given-names></name><name><surname>Iqbal</surname><given-names>J.</given-names></name><name><surname>Holtfreter</surname><given-names>S.</given-names></name><name><surname>Section</surname><given-names>M.G.</given-names></name><name><surname>Diseases</surname><given-names>I.</given-names></name></person-group><article-title>Fighting <italic>Staphylococcus aureus</italic> biofilms with monoclonal antibodies</article-title><source>Trends Microbiol.</source><year>2019</year><volume>27</volume><fpage>303</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2018.12.009</pub-id><pub-id pub-id-type="pmid">30665698</pub-id></element-citation></ref><ref id="B48-pathogens-10-00091"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verkaik</surname><given-names>N.J.</given-names></name><name><surname>Van Wamel</surname><given-names>W.J.</given-names></name><name><surname>Van Belkum</surname><given-names>A.</given-names></name></person-group><article-title>Immunotherapeutic approaches against <italic>Staphylococcus aureus</italic></article-title><source>Immunotherapy</source><year>2011</year><volume>3</volume><fpage>1063</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.2217/imt.11.84</pub-id><pub-id pub-id-type="pmid">21913829</pub-id></element-citation></ref><ref id="B49-pathogens-10-00091"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Qian</surname><given-names>M.</given-names></name><name><surname>Yi</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Yu</surname><given-names>R.</given-names></name><name><surname>Guo</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Monoclonal antibody targeting <italic>Staphylococcus aureus</italic> surface protein A (SasA) protect against <italic>Staphylococcus aureus</italic> sepsis and peritonitis in mice</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0149460</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0149460</pub-id><pub-id pub-id-type="pmid">26926145</pub-id></element-citation></ref><ref id="B50-pathogens-10-00091"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Thompson</surname><given-names>C.D.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Lee</surname><given-names>J.C.</given-names></name></person-group><article-title>Antibodies to <italic>Staphylococcus aureus</italic> capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo</article-title><source>Virulence</source><year>2017</year><volume>8</volume><fpage>859</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1080/21505594.2016.1270494</pub-id><pub-id pub-id-type="pmid">27936346</pub-id></element-citation></ref><ref id="B51-pathogens-10-00091"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar</surname><given-names>J.L.</given-names></name><name><surname>Varshney</surname><given-names>A.K.</given-names></name><name><surname>Pechuan</surname><given-names>X.</given-names></name><name><surname>Dutta</surname><given-names>K.</given-names></name><name><surname>Nosanchuk</surname><given-names>J.D.</given-names></name><name><surname>Fries</surname><given-names>B.C.</given-names></name></person-group><article-title>Monoclonal antibodies protect from staphylococcal enterotoxin K (SEK) induced toxic shock and sepsis by USA300 <italic>Staphylococcus aureus</italic></article-title><source>Virulence</source><year>2017</year><volume>8</volume><fpage>741</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1080/21505594.2016.1231295</pub-id><?supplied-pmid 27715466?><pub-id pub-id-type="pmid">27715466</pub-id></element-citation></ref><ref id="B52-pathogens-10-00091"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Karauzum</surname><given-names>H.</given-names></name><name><surname>Long</surname><given-names>H.</given-names></name><name><surname>Carranza</surname><given-names>D.</given-names></name><name><surname>Holtsberg</surname><given-names>F.W.</given-names></name><name><surname>Howell</surname><given-names>K.A.</given-names></name><name><surname>Abaandou</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Jarvik</surname><given-names>N.</given-names></name><name><surname>Ye</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Potent neutralization of staphylococcal enterotoxin B in vivo by antibodies that block binding to the T-cell receptor</article-title><source>J. Mol. Biol.</source><year>2019</year><volume>431</volume><fpage>4354</fpage><lpage>4367</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2019.03.017</pub-id><?supplied-pmid 30928493?><pub-id pub-id-type="pmid">30928493</pub-id></element-citation></ref><ref id="B53-pathogens-10-00091"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mourenza</surname><given-names>&#x000c1;.</given-names></name><name><surname>Gil</surname><given-names>J.A.</given-names></name><name><surname>Mateos</surname><given-names>L.M.</given-names></name><name><surname>Letek</surname><given-names>M.</given-names></name></person-group><article-title>Alternative anti-infective treatments to traditional antibiotherapy against staphylococcal veterinary pathogens</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>702</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9100702</pub-id><?supplied-pmid 33076497?><pub-id pub-id-type="pmid">33076497</pub-id></element-citation></ref><ref id="B54-pathogens-10-00091"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>S.A.</given-names></name><name><surname>Tiemann</surname><given-names>K.M.</given-names></name><name><surname>Hogan</surname><given-names>P.G.</given-names></name><name><surname>Epplin</surname><given-names>E.K.</given-names></name><name><surname>Rodriguez</surname><given-names>M.</given-names></name><name><surname>Al-Zubeidi</surname><given-names>D.N.</given-names></name><name><surname>Wardenburg</surname><given-names>J.B.</given-names></name><name><surname>Hunstad</surname><given-names>D.A.</given-names></name></person-group><article-title>A serologic correlate of protective immunity against community-onset <italic>Staphylococcus aureus</italic> infection</article-title><source>Clin. Infect. Dis.</source><year>2013</year><volume>56</volume><fpage>1554</fpage><lpage>1561</lpage><pub-id pub-id-type="doi">10.1093/cid/cit123</pub-id><?supplied-pmid 23446627?><pub-id pub-id-type="pmid">23446627</pub-id></element-citation></ref><ref id="B55-pathogens-10-00091"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adhikari</surname><given-names>R.P.</given-names></name><name><surname>Karauzum</surname><given-names>H.</given-names></name><name><surname>Sarwar</surname><given-names>J.</given-names></name><name><surname>Abaandou</surname><given-names>L.</given-names></name><name><surname>Mahmoudieh</surname><given-names>M.</given-names></name><name><surname>Boroun</surname><given-names>A.R.</given-names></name><name><surname>Vu</surname><given-names>H.</given-names></name><name><surname>Nguyen</surname><given-names>T.</given-names></name><name><surname>Devi</surname><given-names>V.S.</given-names></name><name><surname>Shulenin</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Novel structurally designed vaccine for <italic>S. aureus</italic> &#x003b1;-hemolysin: Protection against bacteremia and pneumonia</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><pub-id pub-id-type="doi">10.1371/journal.pone.0038567</pub-id></element-citation></ref><ref id="B56-pathogens-10-00091"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonventre</surname><given-names>P.F.</given-names></name><name><surname>Linnemann</surname><given-names>C.</given-names></name><name><surname>Weckbach</surname><given-names>L.S.</given-names></name><name><surname>Staneck</surname><given-names>J.L.</given-names></name><name><surname>Buncher</surname><given-names>C.R.</given-names></name><name><surname>Vigdorth</surname><given-names>E.</given-names></name><name><surname>Ritz</surname><given-names>H.</given-names></name><name><surname>Archer</surname><given-names>D.</given-names></name><name><surname>Smith</surname><given-names>B.</given-names></name></person-group><article-title>Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers</article-title><source>J. Infect. Dis.</source><year>1984</year><volume>150</volume><fpage>662</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1093/infdis/150.5.662</pub-id><pub-id pub-id-type="pmid">6491377</pub-id></element-citation></ref><ref id="B57-pathogens-10-00091"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolz</surname><given-names>S.J.</given-names></name><name><surname>Davis</surname><given-names>J.P.</given-names></name><name><surname>Vergeront</surname><given-names>J.M.</given-names></name><name><surname>Crass</surname><given-names>B.A.</given-names></name><name><surname>Chesney</surname><given-names>P.J.</given-names></name><name><surname>Wand</surname><given-names>P.J.</given-names></name><name><surname>Bergdoll</surname><given-names>M.S.</given-names></name></person-group><article-title>Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in wisconsin</article-title><source>J. Infect. Dis.</source><year>1985</year><volume>151</volume><fpage>883</fpage><lpage>889</lpage><pub-id pub-id-type="doi">10.1093/infdis/151.5.883</pub-id><pub-id pub-id-type="pmid">3989322</pub-id></element-citation></ref><ref id="B58-pathogens-10-00091"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vergeront</surname><given-names>J.M.</given-names></name><name><surname>Stolz</surname><given-names>S.J.</given-names></name><name><surname>Crass</surname><given-names>B.A.</given-names></name><name><surname>Nelson</surname><given-names>D.B.</given-names></name><name><surname>Davis</surname><given-names>J.P.</given-names></name><name><surname>Bergdoll</surname><given-names>M.S.</given-names></name></person-group><article-title>Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: Implications for toxic-shock syndrome</article-title><source>J. Infect. Dis.</source><year>1983</year><volume>148</volume><fpage>692</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1093/infdis/148.4.692</pub-id><pub-id pub-id-type="pmid">6631061</pub-id></element-citation></ref><ref id="B59-pathogens-10-00091"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roetzer</surname><given-names>A.</given-names></name><name><surname>Stich</surname><given-names>N.</given-names></name><name><surname>Model</surname><given-names>N.</given-names></name><name><surname>Schwameis</surname><given-names>M.</given-names></name><name><surname>Firbas</surname><given-names>C.</given-names></name><name><surname>Jilma</surname><given-names>B.</given-names></name><name><surname>Eibl</surname><given-names>M.M.</given-names></name></person-group><article-title>High titer persistent neutralizing antibodies induced by TSST-1 variant vaccine against toxic shock cytokine storm</article-title><source>Toxins</source><year>2020</year><volume>12</volume><elocation-id>640</elocation-id><pub-id pub-id-type="doi">10.3390/toxins12100640</pub-id></element-citation></ref><ref id="B60-pathogens-10-00091"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>D.L.</given-names></name><name><surname>Omoe</surname><given-names>K.</given-names></name><name><surname>Sasaki</surname><given-names>S.</given-names></name><name><surname>Sashinami</surname><given-names>H.</given-names></name><name><surname>Sakuraba</surname><given-names>H.</given-names></name><name><surname>Yokomizo</surname><given-names>Y.</given-names></name><name><surname>Shinagawa</surname><given-names>K.</given-names></name><name><surname>Nakane</surname><given-names>A.</given-names></name></person-group><article-title>Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against <italic>Staphylococcus aureus</italic> infection</article-title><source>J. Infect. Dis.</source><year>2003</year><volume>188</volume><fpage>743</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1086/377308</pub-id><pub-id pub-id-type="pmid">12934191</pub-id></element-citation></ref><ref id="B61-pathogens-10-00091"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>M.R.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Bombardi</surname><given-names>R.G.</given-names></name><name><surname>Soto</surname><given-names>C.</given-names></name><name><surname>Parrington</surname><given-names>H.M.</given-names></name><name><surname>Nargi</surname><given-names>R.S.</given-names></name><name><surname>Schoeder</surname><given-names>C.T.</given-names></name><name><surname>Nagel</surname><given-names>M.B.</given-names></name><name><surname>Schey</surname><given-names>K.L.</given-names></name><name><surname>Meiler</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Human VH1-69 gene-encoded human monoclonal antibody against <italic>Staphylococcus aureus</italic> IsdB use at least three distinct pathogenesis</article-title><source>MBio</source><year>2019</year><volume>10</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1128/mBio.02473-19</pub-id><?supplied-pmid 31641091?><pub-id pub-id-type="pmid">31641091</pub-id></element-citation></ref><ref id="B62-pathogens-10-00091"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Yagiz</surname><given-names>Y.</given-names></name><name><surname>Hsu</surname><given-names>W.Y.</given-names></name><name><surname>Simonne</surname><given-names>A.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Marshall</surname><given-names>M.R.</given-names></name></person-group><article-title>Antioxidant, antibacterial, and antibiofilm properties of polyphenols from muscadine grape (<italic>Vitis rotundifolia Michx.</italic>) Pomace against selected foodborne pathogens</article-title><source>J. Agric. Food Chem.</source><year>2014</year><volume>62</volume><fpage>6640</fpage><lpage>6649</lpage><pub-id pub-id-type="doi">10.1021/jf501073q</pub-id><?supplied-pmid 24865879?><pub-id pub-id-type="pmid">24865879</pub-id></element-citation></ref><ref id="B63-pathogens-10-00091"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harro</surname><given-names>J.M.</given-names></name><name><surname>Peters</surname><given-names>B.M.</given-names></name><name><surname>O&#x02019;May</surname><given-names>G.A.</given-names></name><name><surname>Archer</surname><given-names>N.</given-names></name><name><surname>Kerns</surname><given-names>P.</given-names></name><name><surname>Prabhakara</surname><given-names>R.</given-names></name><name><surname>Shirtliff</surname><given-names>M.E.</given-names></name></person-group><article-title>Vaccine development in <italic>Staphylococcus aureus</italic>: Taking the biofilm phenotype into consideration</article-title><source>FEMS Immunol. Med. Microbiol.</source><year>2010</year><volume>59</volume><fpage>306</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2010.00708.x</pub-id><?supplied-pmid 20602638?><pub-id pub-id-type="pmid">20602638</pub-id></element-citation></ref><ref id="B64-pathogens-10-00091"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.C.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Zhu</surname><given-names>K.</given-names></name><name><surname>Shen</surname><given-names>J.Z.</given-names></name></person-group><article-title>Natural products that target virulence factors in antibiotic-resistant <italic>Staphylococcus aureus</italic></article-title><source>J. Agric. Food Chem.</source><year>2019</year><volume>67</volume><fpage>13195</fpage><lpage>13211</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.9b05595</pub-id><?supplied-pmid 31702908?><pub-id pub-id-type="pmid">31702908</pub-id></element-citation></ref><ref id="B65-pathogens-10-00091"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Defoirdt</surname><given-names>T.</given-names></name></person-group><article-title>Antivirulence therapy for animal production: Filling an arsenal with novel weapons for sustainable disease control</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003603</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003603</pub-id><?supplied-pmid 24130477?><pub-id pub-id-type="pmid">24130477</pub-id></element-citation></ref><ref id="B66-pathogens-10-00091"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Said</surname><given-names>A.</given-names></name><name><surname>Naeem</surname><given-names>N.</given-names></name><name><surname>Siraj</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>T.</given-names></name><name><surname>Javed</surname><given-names>A.</given-names></name><name><surname>Rasheed</surname><given-names>H.M.</given-names></name><name><surname>Sajjad</surname><given-names>W.</given-names></name><name><surname>Shah</surname><given-names>K.</given-names></name><name><surname>Wahid</surname><given-names>F.</given-names></name></person-group><article-title>Mechanisms underlying the wound healing and tissue regeneration properties of <italic>Chenopodium album</italic></article-title><source>3 Biotech</source><year>2020</year><volume>10</volume><fpage>452</fpage><pub-id pub-id-type="doi">10.1007/s13205-020-02436-6</pub-id></element-citation></ref><ref id="B67-pathogens-10-00091"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulet</surname><given-names>M.L.</given-names></name><name><surname>Charles</surname><given-names>I.</given-names></name><name><surname>Guay</surname><given-names>I.</given-names></name><name><surname>Brouillette</surname><given-names>E.</given-names></name><name><surname>Langlois</surname><given-names>J.-P.</given-names></name><name><surname>Jacques</surname><given-names>P.</given-names></name><name><surname>Rodrigue</surname><given-names>S.</given-names></name><name><surname>Brzezinski</surname><given-names>R.</given-names></name><name><surname>Beauregard</surname><given-names>P.B.</given-names></name><name><surname>Bouarab</surname><given-names>K.</given-names></name></person-group><article-title>Tomatidine is a lead antibiotic molecule that targets <italic>Staphylococcus aureus</italic> ATP synthasesubunit C</article-title><source>Antimicrob. Agents Chemother.</source><year>2018</year><volume>62</volume><fpage>1</fpage><lpage>18</lpage></element-citation></ref><ref id="B68-pathogens-10-00091"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>G.</given-names></name><name><surname>Gattuso</surname><given-names>M.</given-names></name><name><surname>Grondin</surname><given-names>G.</given-names></name><name><surname>Marsault</surname><given-names>&#x000c9;.</given-names></name><name><surname>Bouarab</surname><given-names>K.</given-names></name><name><surname>Malouin</surname><given-names>F.</given-names></name></person-group><article-title>Tomatidine inhibits replication of <italic>Staphylococcus aureus</italic> small-colony variants in cystic fibrosis airway epithelial cells</article-title><source>Antimicrob. Agents Chemother.</source><year>2011</year><volume>55</volume><fpage>1937</fpage><lpage>1945</lpage><pub-id pub-id-type="doi">10.1128/AAC.01468-10</pub-id><pub-id pub-id-type="pmid">21357296</pub-id></element-citation></ref><ref id="B69-pathogens-10-00091"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>G.</given-names></name><name><surname>Lafrance</surname><given-names>M.</given-names></name><name><surname>Boulanger</surname><given-names>S.</given-names></name><name><surname>S&#x000e9;guin</surname><given-names>D.L.</given-names></name><name><surname>Guay</surname><given-names>I.</given-names></name><name><surname>Gattuso</surname><given-names>M.</given-names></name><name><surname>Marsault</surname><given-names>&#x000c9;.</given-names></name><name><surname>Bouarab</surname><given-names>K.</given-names></name><name><surname>Malouin</surname><given-names>F.</given-names></name></person-group><article-title>Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant <italic>Staphylococcus aureus</italic> and prevents virulence gene expression</article-title><source>J. Antimicrob. Chemother.</source><year>2012</year><volume>67</volume><fpage>559</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1093/jac/dkr510</pub-id><pub-id pub-id-type="pmid">22129590</pub-id></element-citation></ref><ref id="B70-pathogens-10-00091"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leng</surname><given-names>B.F.</given-names></name><name><surname>Qiu</surname><given-names>J.Z.</given-names></name><name><surname>Dai</surname><given-names>X.H.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.F.</given-names></name><name><surname>Luo</surname><given-names>M.J.</given-names></name><name><surname>Li</surname><given-names>H.E.</given-names></name><name><surname>Niu</surname><given-names>X.-D.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ai</surname><given-names>Y.X.</given-names></name><etal/></person-group><article-title>Allicin reduces the production of &#x003b1;-toxin by <italic>Staphylococcus aureus</italic></article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>7958</fpage><lpage>7968</lpage><pub-id pub-id-type="doi">10.3390/molecules16097958</pub-id><pub-id pub-id-type="pmid">21921868</pub-id></element-citation></ref><ref id="B71-pathogens-10-00091"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>S.</given-names></name><name><surname>Kushiya</surname><given-names>K.</given-names></name><name><surname>Taneike</surname><given-names>I.</given-names></name><name><surname>Imanishi</surname><given-names>K.</given-names></name><name><surname>Uchiyama</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name></person-group><article-title>Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice</article-title><source>Clin. Diagn. Lab. Immunol.</source><year>2005</year><volume>12</volume><fpage>399</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1128/CDLI.12.3.399-408.2005</pub-id><?supplied-pmid 15753253?><pub-id pub-id-type="pmid">15753253</pub-id></element-citation></ref><ref id="B72-pathogens-10-00091"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.M.</given-names></name><name><surname>Ou</surname><given-names>Z.L.</given-names></name><name><surname>Gondaira</surname><given-names>F.</given-names></name><name><surname>Ohmura</surname><given-names>M.</given-names></name><name><surname>Kojio</surname><given-names>S.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name></person-group><article-title>Protective effect of anisodamine against Shiga toxin-1: Inhibition of cytokine production and increase in the survival of mice</article-title><source>J. Lab. Clin. Med.</source><year>2001</year><volume>137</volume><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1067/mlc.2001.112507</pub-id><?supplied-pmid 11174465?><pub-id pub-id-type="pmid">11174465</pub-id></element-citation></ref><ref id="B73-pathogens-10-00091"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>C.</given-names></name><name><surname>Neoh</surname><given-names>H.M.</given-names></name><name><surname>Nathan</surname><given-names>S.</given-names></name></person-group><article-title>Targeting <italic>Staphylococcus aureus</italic> toxins: A potential form of anti-virulence therapy</article-title><source>Toxins</source><year>2016</year><volume>8</volume><elocation-id>72</elocation-id><pub-id pub-id-type="doi">10.3390/toxins8030072</pub-id><?supplied-pmid 26999200?><pub-id pub-id-type="pmid">26999200</pub-id></element-citation></ref><ref id="B74-pathogens-10-00091"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.F.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>J.Y.</given-names></name><name><surname>Wang</surname><given-names>Y.N.</given-names></name><name><surname>Dai</surname><given-names>X.H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>M.J.</given-names></name><name><surname>Tan</surname><given-names>W.</given-names></name><name><surname>Deng</surname><given-names>X.M.</given-names></name><etal/></person-group><article-title>Inhibition of &#x003b1;-toxin production by subinhibitory concentrations of naringenin controls <italic>Staphylococcus aureus</italic> pneumonia</article-title><source>Fitoterapia</source><year>2013</year><volume>86</volume><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2013.02.001</pub-id><pub-id pub-id-type="pmid">23425602</pub-id></element-citation></ref><ref id="B75-pathogens-10-00091"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castello</surname><given-names>F.</given-names></name><name><surname>Fern&#x000e1;ndez-Pach&#x000f3;n</surname><given-names>M.S.</given-names></name><name><surname>Cerrillo</surname><given-names>I.</given-names></name><name><surname>Escudero-L&#x000f3;pez</surname><given-names>B.</given-names></name><name><surname>Ortega</surname><given-names>&#x000c1;.</given-names></name><name><surname>Rosi</surname><given-names>A.</given-names></name><name><surname>Bresciani</surname><given-names>L.</given-names></name><name><surname>Del Rio</surname><given-names>D.</given-names></name><name><surname>Mena</surname><given-names>P.</given-names></name></person-group><article-title>Absorption, metabolism, and excretion of orange juice (poly)phenols in humans: The effect of a controlled alcoholic fermentation</article-title><source>Arch. Biochem. Biophys.</source><year>2020</year><volume>695</volume><pub-id pub-id-type="doi">10.1016/j.abb.2020.108627</pub-id></element-citation></ref><ref id="B76-pathogens-10-00091"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>H.</given-names></name><name><surname>Xiang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Xia</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>K.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name></person-group><article-title>Influence of subinhibitory concentrations of licochalcone A on the secretion of enterotoxins A and B by <italic>Staphylococcus aureus</italic></article-title><source>FEMS Microbiol. Lett.</source><year>2010</year><volume>307</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2010.01973.x</pub-id><pub-id pub-id-type="pmid">20412304</pub-id></element-citation></ref><ref id="B77-pathogens-10-00091"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Gong</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name><name><surname>Duo</surname><given-names>K.</given-names></name><name><surname>Fei</surname><given-names>P.</given-names></name></person-group><article-title>Antibacterial Activity of Olive Oil Polyphenol Extract Against <italic>Salmonella</italic> Typhimurium and <italic>Staphylococcus aureus</italic>: Possible Mechanisms</article-title><source>Foodborne Pathog. Dis.</source><year>2020</year><volume>17</volume><fpage>396</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1089/fpd.2019.2713</pub-id><pub-id pub-id-type="pmid">31755743</pub-id></element-citation></ref><ref id="B78-pathogens-10-00091"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>E.</given-names></name><name><surname>Romero</surname><given-names>C.</given-names></name><name><surname>Brenes</surname><given-names>M.</given-names></name><name><surname>De Castro</surname><given-names>A.</given-names></name></person-group><article-title>Antimicrobial activity of olive oil, vinegar, and various beverages against foodborne pathogens</article-title><source>J. Food Prot.</source><year>2007</year><volume>70</volume><fpage>1194</fpage><lpage>1199</lpage><pub-id pub-id-type="doi">10.4315/0362-028X-70.5.1194</pub-id><pub-id pub-id-type="pmid">17536679</pub-id></element-citation></ref><ref id="B79-pathogens-10-00091"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenes</surname><given-names>M.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>A.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>P.</given-names></name><name><surname>Rios</surname><given-names>J.J.</given-names></name><name><surname>Garrido</surname><given-names>A.</given-names></name></person-group><article-title>Phenolic compounds in Spanish olive oils</article-title><source>J. Agric. Food Chem.</source><year>1999</year><volume>47</volume><fpage>3535</fpage><lpage>3540</lpage><pub-id pub-id-type="doi">10.1021/jf990009o</pub-id><pub-id pub-id-type="pmid">10552681</pub-id></element-citation></ref><ref id="B80-pathogens-10-00091"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenes</surname><given-names>M.</given-names></name><name><surname>Hidalgo</surname><given-names>F.J.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>A.</given-names></name><name><surname>Rios</surname><given-names>J.J.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>P.</given-names></name><name><surname>Zamora</surname><given-names>R.</given-names></name><name><surname>Garrido</surname><given-names>A.</given-names></name></person-group><article-title>Pinoresinol and 1-acetoxypinoresinol, two new phenolic compounds identified in olive oil</article-title><source>JAOCS J. Am. Oil Chem. Soc.</source><year>2000</year><volume>77</volume><fpage>715</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1007/s11746-000-0115-4</pub-id></element-citation></ref><ref id="B81-pathogens-10-00091"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tovar</surname><given-names>M.J.</given-names></name><name><surname>Motilva</surname><given-names>M.J.</given-names></name><name><surname>Romero</surname><given-names>M.P.</given-names></name></person-group><article-title>Changes in the phenolic composition of virgin olive oil from young trees (<italic>Olea europaea</italic> L. cv. Arbequina) grown under linear irrigation strategies</article-title><source>J. Agric. Food Chem.</source><year>2001</year><volume>49</volume><fpage>5502</fpage><lpage>5508</lpage><pub-id pub-id-type="doi">10.1021/jf0102416</pub-id><?supplied-pmid 11714351?><pub-id pub-id-type="pmid">11714351</pub-id></element-citation></ref><ref id="B82-pathogens-10-00091"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>M.</given-names></name><name><surname>Rasooly</surname><given-names>R.</given-names></name><name><surname>Do</surname><given-names>P.M.</given-names></name><name><surname>Henika</surname><given-names>P.R.</given-names></name></person-group><article-title>The Olive Compound 4-Hydroxytyrosol Inactivates <italic>Staphylococcus aureus</italic> Bacteria and Staphylococcal Enterotoxin A (SEA)</article-title><source>J. Food Sci.</source><year>2011</year><volume>76</volume><pub-id pub-id-type="doi">10.1111/j.1750-3841.2011.02365.x</pub-id><?supplied-pmid 22417596?><pub-id pub-id-type="pmid">22417596</pub-id></element-citation></ref><ref id="B83-pathogens-10-00091"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Mart&#x000ed;nez</surname><given-names>O.</given-names></name><name><surname>De Luna-Bertos</surname><given-names>E.</given-names></name><name><surname>Ramos-Torrecillas</surname><given-names>J.</given-names></name><name><surname>Ruiz</surname><given-names>C.</given-names></name><name><surname>Milia</surname><given-names>E.</given-names></name><name><surname>Lorenzo</surname><given-names>M.L.</given-names></name><name><surname>Jimenez</surname><given-names>B.</given-names></name><name><surname>S&#x000e1;nchez-Ortiz</surname><given-names>A.</given-names></name><name><surname>Rivas</surname><given-names>A.</given-names></name></person-group><article-title>Phenolic compounds in extra virgin olive oil stimulate human osteoblastic cell proliferation</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0150045</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0150045</pub-id><?supplied-pmid 26930190?><pub-id pub-id-type="pmid">26930190</pub-id></element-citation></ref><ref id="B84-pathogens-10-00091"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Xiang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name></person-group><article-title>Eugenol reduces the expression of virulence-related exoproteins in <italic>Staphylococcus aureus</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2010</year><volume>76</volume><fpage>5846</fpage><lpage>5851</lpage><pub-id pub-id-type="doi">10.1128/AEM.00704-10</pub-id><?supplied-pmid 20639367?><pub-id pub-id-type="pmid">20639367</pub-id></element-citation></ref><ref id="B85-pathogens-10-00091"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiran</surname><given-names>M.D.</given-names></name><name><surname>Adikesavan</surname><given-names>N.V.</given-names></name><name><surname>Cirioni</surname><given-names>O.</given-names></name><name><surname>Giacometti</surname><given-names>A.</given-names></name><name><surname>Silvestri</surname><given-names>C.</given-names></name><name><surname>Scalise</surname><given-names>G.</given-names></name><name><surname>Ghiselli</surname><given-names>R.</given-names></name><name><surname>Saba</surname><given-names>V.</given-names></name><name><surname>Orlando</surname><given-names>F.</given-names></name><name><surname>Shoham</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening</article-title><source>Mol. Pharmacol.</source><year>2008</year><volume>73</volume><fpage>1578</fpage><lpage>1586</lpage><pub-id pub-id-type="doi">10.1124/mol.107.044164</pub-id><pub-id pub-id-type="pmid">18314496</pub-id></element-citation></ref><ref id="B86-pathogens-10-00091"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>H.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name></person-group><article-title>Menthol diminishes <italic>Staphylococcus aureus</italic> virulence-associated extracellular proteins expression</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2011</year><volume>90</volume><fpage>705</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1007/s00253-011-3122-9</pub-id><pub-id pub-id-type="pmid">21287163</pub-id></element-citation></ref><ref id="B87-pathogens-10-00091"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozalski</surname><given-names>M.</given-names></name><name><surname>Micota</surname><given-names>B.</given-names></name><name><surname>Sadowska</surname><given-names>B.</given-names></name><name><surname>Stochmal</surname><given-names>A.</given-names></name><name><surname>Jedrejek</surname><given-names>D.</given-names></name><name><surname>Wieckowska-Szakiel</surname><given-names>M.</given-names></name><name><surname>Rozalska</surname><given-names>B.</given-names></name></person-group><article-title>Antiadherent and antibiofilm activity of <italic>Humulus lupulus</italic> L. derived products: New pharmacological properties</article-title><source>Biomed Res. Int.</source><year>2013</year><volume>2013</volume><fpage>101089</fpage><pub-id pub-id-type="doi">10.1155/2013/101089</pub-id><pub-id pub-id-type="pmid">24175280</pub-id></element-citation></ref><ref id="B88-pathogens-10-00091"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname><given-names>A.</given-names></name><name><surname>Simoes</surname><given-names>L.C.</given-names></name><name><surname>Saavedra</surname><given-names>M.J.</given-names></name><name><surname>Simoes</surname><given-names>M.</given-names></name></person-group><article-title>The action of selected isothiocyanates on bacterial biofilm prevention and control</article-title><source>Int. Biodeterior. Biodegrad.</source><year>2014</year><volume>86</volume><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.ibiod.2013.01.015</pub-id></element-citation></ref><ref id="B89-pathogens-10-00091"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>W.N.C.</given-names></name><name><surname>de Oliveira</surname><given-names>L.G.P.</given-names></name><name><surname>Santos</surname><given-names>C.S.</given-names></name><name><surname>Dias</surname><given-names>G.N.</given-names></name><name><surname>Pimenta</surname><given-names>A.S.</given-names></name><name><surname>Pereira</surname><given-names>A.F.</given-names></name><name><surname>Moreira</surname><given-names>L.D.</given-names></name><name><surname>Marlon</surname><given-names>F.</given-names></name><name><surname>Feij&#x000f3;</surname><given-names>C.</given-names></name></person-group><article-title>Pyroligneous acid from <italic>Mimosa tenuiflora</italic> and <italic>Eucalyptus urograndis</italic> as an antimicrobial in dairy goats</article-title><source>J. Appl. Microbiol.</source><year>2020</year><pub-id pub-id-type="doi">10.1111/jam.14977</pub-id></element-citation></ref><ref id="B90-pathogens-10-00091"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallavan</surname><given-names>V.</given-names></name><name><surname>Krishnasamy</surname><given-names>G.</given-names></name><name><surname>Zin</surname><given-names>N.M.</given-names></name><name><surname>Latif</surname><given-names>M.A.</given-names></name></person-group><article-title>A review on antistaphylococcal secondary metabolites from Basidiomycetes</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>5848</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25245848</pub-id></element-citation></ref><ref id="B91-pathogens-10-00091"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finimundy</surname><given-names>T.C.</given-names></name><name><surname>Barros</surname><given-names>L.</given-names></name><name><surname>Calhelha</surname><given-names>R.C.</given-names></name><name><surname>Alves</surname><given-names>M.J.</given-names></name><name><surname>Prieto</surname><given-names>M.A.</given-names></name><name><surname>Abreu</surname><given-names>R.M.V.</given-names></name><name><surname>Dillon</surname><given-names>A.J.P.</given-names></name><name><surname>Henriques</surname><given-names>J.A.P.</given-names></name><name><surname>Roesch-Ely</surname><given-names>M.</given-names></name><name><surname>Ferreira</surname><given-names>I.C.F.R.</given-names></name></person-group><article-title>Multifunctions of <italic>Pleurotus sajor-caju (Fr.) Singer</italic>: A highly nutritious food and a source for bioactive compounds</article-title><source>Food Chem.</source><year>2018</year><volume>245</volume><fpage>150</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2017.10.088</pub-id><pub-id pub-id-type="pmid">29287356</pub-id></element-citation></ref><ref id="B92-pathogens-10-00091"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combarros-fuertes</surname><given-names>P.</given-names></name><name><surname>Fresno</surname><given-names>J.M.</given-names></name><name><surname>Estevinho</surname><given-names>M.M.</given-names></name><name><surname>Sousa-Pimenta</surname><given-names>M.</given-names></name><name><surname>Tornadijo</surname><given-names>M.E.</given-names></name><name><surname>Estevinho</surname><given-names>L.M.</given-names></name></person-group><article-title>Honey: Another alternative in the fight against antibiotic-resistant bacteria?</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>774</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9110774</pub-id><?supplied-pmid 33158063?><pub-id pub-id-type="pmid">33158063</pub-id></element-citation></ref><ref id="B93-pathogens-10-00091"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masoura</surname><given-names>M.</given-names></name><name><surname>Passaretti</surname><given-names>P.</given-names></name><name><surname>Overton</surname><given-names>T.W.</given-names></name><name><surname>Lund</surname><given-names>P.A.</given-names></name></person-group><article-title>Use of a model to understand the synergies underlying the antibacterial mechanism of H<sub>2</sub>O<sub>2</sub>-producing honeys</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>17692</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-74937-6</pub-id><?supplied-pmid 33077785?><pub-id pub-id-type="pmid">33077785</pub-id></element-citation></ref><ref id="B94-pathogens-10-00091"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fyfe</surname><given-names>L.</given-names></name><name><surname>Okoro</surname><given-names>P.</given-names></name><name><surname>Paterson</surname><given-names>E.</given-names></name><name><surname>Coyle</surname><given-names>S.</given-names></name><name><surname>McDougall</surname><given-names>G.J.</given-names></name></person-group><article-title>Compositional analysis of Scottish honeys with antimicrobial activity against antibiotic-resistant bacteria reveals novel antimicrobial components</article-title><source>LWT Food Sci. Technol.</source><year>2017</year><volume>79</volume><fpage>52</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2017.01.023</pub-id></element-citation></ref><ref id="B95-pathogens-10-00091"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godocikova</surname><given-names>J.</given-names></name><name><surname>Bugarova</surname><given-names>V.</given-names></name><name><surname>Kast</surname><given-names>C.</given-names></name><name><surname>Majtan</surname><given-names>V.</given-names></name><name><surname>Majtan</surname><given-names>J.</given-names></name></person-group><article-title>Antibacterial potential of Swiss honeys and characterisation of their bee-derived bioactive compounds</article-title><source>J. Sci. Food Agric.</source><year>2020</year><volume>100</volume><fpage>335</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1002/jsfa.10043</pub-id><?supplied-pmid 31584691?><pub-id pub-id-type="pmid">31584691</pub-id></element-citation></ref><ref id="B96-pathogens-10-00091"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almuhayawi</surname><given-names>M.S.</given-names></name></person-group><article-title>Propolis as a novel antibacterial agent</article-title><source>Saudi J. Biol. Sci.</source><year>2020</year><volume>27</volume><fpage>3079</fpage><lpage>3086</lpage><pub-id pub-id-type="doi">10.1016/j.sjbs.2020.09.016</pub-id><?supplied-pmid 33100868?><pub-id pub-id-type="pmid">33100868</pub-id></element-citation></ref><ref id="B97-pathogens-10-00091"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Przyby&#x00142;ek</surname><given-names>I.</given-names></name><name><surname>Karpi&#x00144;ski</surname><given-names>T.M.</given-names></name></person-group><article-title>Antibacterial properties of propolis</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2047</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24112047</pub-id><?supplied-pmid 31146392?><pub-id pub-id-type="pmid">31146392</pub-id></element-citation></ref><ref id="B98-pathogens-10-00091"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>M.</given-names></name><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Leng</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Dai</surname><given-names>X.</given-names></name><name><surname>Niu</surname><given-names>X.</given-names></name><etal/></person-group><article-title>&#x003b1;-Cyperone alleviates lung cell injury caused by <italic>Staphylococcus aureus</italic> via attenuation of &#x003b1;-Hemolysin expression</article-title><source>J. Microbiol. Biotechnol.</source><year>2012</year><volume>22</volume><fpage>1170</fpage><lpage>1176</lpage><pub-id pub-id-type="doi">10.4014/jmb.1202.02017</pub-id><pub-id pub-id-type="pmid">22713997</pub-id></element-citation></ref><ref id="B99-pathogens-10-00091"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igarashi</surname><given-names>Y.</given-names></name><name><surname>Gohda</surname><given-names>F.</given-names></name><name><surname>Kadoshima</surname><given-names>T.</given-names></name><name><surname>Fukuda</surname><given-names>T.</given-names></name><name><surname>Hanafusa</surname><given-names>T.</given-names></name><name><surname>Shojima</surname><given-names>A.</given-names></name><name><surname>Nakayama</surname><given-names>J.</given-names></name><name><surname>Bills</surname><given-names>G.F.</given-names></name><name><surname>Peterson</surname><given-names>S.</given-names></name></person-group><article-title>Avellanin C, an inhibitor of quorum-sensing signaling in <italic>Staphylococcus aureus</italic>, from Hamigera ingelheimensis</article-title><source>J. Antibiot.</source><year>2015</year><volume>68</volume><fpage>707</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1038/ja.2015.50</pub-id><?supplied-pmid 25944536?><pub-id pub-id-type="pmid">25944536</pub-id></element-citation></ref><ref id="B100-pathogens-10-00091"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Oliveira</surname><given-names>M.L.A.</given-names></name><name><surname>Ponciano</surname><given-names>C.S.</given-names></name><name><surname>Cataneo</surname><given-names>A.H.D.</given-names></name><name><surname>Wowk</surname><given-names>P.F.</given-names></name><name><surname>Bordignon</surname><given-names>J.</given-names></name><name><surname>Silva</surname><given-names>H.</given-names></name><name><surname>de Almeida</surname><given-names>M.V.</given-names></name><name><surname>&#x000c1;vila</surname><given-names>E.P.</given-names></name></person-group><article-title>The anti-Zika virus and anti-tumoral activity of the citrus flavanone lipophilic naringenin-based compounds</article-title><source>Chem. Biol. Interact.</source><year>2020</year><volume>331</volume><pub-id pub-id-type="doi">10.1016/j.cbi.2020.109218</pub-id></element-citation></ref><ref id="B101-pathogens-10-00091"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzzo</surname><given-names>F.</given-names></name><name><surname>Scognamiglio</surname><given-names>M.</given-names></name><name><surname>Fiorentino</surname><given-names>A.</given-names></name><name><surname>Buommino</surname><given-names>E.</given-names></name><name><surname>D&#x02019;Abrosca</surname><given-names>B.</given-names></name></person-group><article-title>Plant Derived Natural Products against <italic>Pseudomonas aeruginosa</italic> and <italic>Staphylococcus aureus</italic>: Antibiofilm Activity and Molecular Mechanisms</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>24</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25215024</pub-id><?supplied-pmid 33138250?><pub-id pub-id-type="pmid">33138250</pub-id></element-citation></ref><ref id="B102-pathogens-10-00091"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suresh</surname><given-names>G.</given-names></name><name><surname>Pakdel</surname><given-names>H.</given-names></name><name><surname>Rouissi</surname><given-names>T.</given-names></name><name><surname>Brar</surname><given-names>S.K.</given-names></name><name><surname>Fliss</surname><given-names>I.</given-names></name><name><surname>Roy</surname><given-names>C.</given-names></name></person-group><article-title>In vitro evaluation of antimicrobial efficacy of pyroligneous acid from softwood mixture</article-title><source>Biotechnol. Res. Innov.</source><year>2019</year><volume>3</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.biori.2019.02.004</pub-id></element-citation></ref><ref id="B103-pathogens-10-00091"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhosle</surname><given-names>S.</given-names></name><name><surname>Ranadive</surname><given-names>K.</given-names></name><name><surname>Bapat</surname><given-names>G.</given-names></name><name><surname>Garad</surname><given-names>S.</given-names></name><name><surname>Deshpande</surname><given-names>G.</given-names></name><name><surname>Vaidya</surname><given-names>J.</given-names></name></person-group><article-title>Taxonomy and diversity of <italic>Ganoderma</italic> from the western parts of Maharashtra (India)</article-title><source>Mycosphere</source><year>2010</year><volume>1</volume><fpage>249</fpage><lpage>262</lpage></element-citation></ref><ref id="B104-pathogens-10-00091"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolan</surname><given-names>V.C.</given-names></name><name><surname>Harrison</surname><given-names>J.</given-names></name><name><surname>Wright</surname><given-names>J.E.E.</given-names></name><name><surname>Cox</surname><given-names>J.A.G.</given-names></name></person-group><article-title>Clinical significance of manuka and medical-grade honey for antibiotic-resistant infections: A systematic review</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>766</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9110766</pub-id><?supplied-pmid 33142845?><pub-id pub-id-type="pmid">33142845</pub-id></element-citation></ref><ref id="B105-pathogens-10-00091"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combarros-Fuertes</surname><given-names>P.</given-names></name><name><surname>Estevinho</surname><given-names>L.M.</given-names></name><name><surname>Dias</surname><given-names>L.G.</given-names></name><name><surname>Castro</surname><given-names>J.M.</given-names></name><name><surname>Tom&#x000e1;s-Barber&#x000e1;n</surname><given-names>F.A.</given-names></name><name><surname>Tornadijo</surname><given-names>M.E.</given-names></name><name><surname>Fresno-Baro</surname><given-names>J.M.</given-names></name></person-group><article-title>Bioactive Components and Antioxidant and Antibacterial Activities of Different Varieties of Honey: A Screening Prior to Clinical Application</article-title><source>J. Agric. Food Chem.</source><year>2019</year><volume>67</volume><fpage>688</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.8b05436</pub-id><pub-id pub-id-type="pmid">30575387</pub-id></element-citation></ref><ref id="B106-pathogens-10-00091"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname><given-names>J.M.</given-names></name><name><surname>de Souza</surname><given-names>E.L.</given-names></name><name><surname>Marques</surname><given-names>G.</given-names></name><name><surname>Meireles</surname><given-names>B.</given-names></name><name><surname>de Magalh&#x000e3;es</surname><given-names>C.&#x000c2;.T.</given-names></name><name><surname>Gull&#x000f3;n</surname><given-names>B.</given-names></name><name><surname>Pintado</surname><given-names>M.M.</given-names></name><name><surname>Magnani</surname><given-names>M.</given-names></name></person-group><article-title>Polyphenolic profile and antioxidant and antibacterial activities of monofloral honeys produced by Meliponini in the Brazilian semiarid region</article-title><source>Food Res. Int.</source><year>2016</year><volume>84</volume><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2016.03.012</pub-id></element-citation></ref><ref id="B107-pathogens-10-00091"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucekova</surname><given-names>M.</given-names></name><name><surname>Jardekova</surname><given-names>L.</given-names></name><name><surname>Juricova</surname><given-names>V.</given-names></name><name><surname>Bugarova</surname><given-names>V.</given-names></name><name><surname>Di Marco</surname><given-names>G.</given-names></name><name><surname>Gismondi</surname><given-names>A.</given-names></name><name><surname>Leonardi</surname><given-names>D.</given-names></name><name><surname>Farkasovska</surname><given-names>J.</given-names></name><name><surname>Godocikova</surname><given-names>J.</given-names></name><name><surname>Laho</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Antibacterial activity of different blossom honeys: New findings</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1573</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24081573</pub-id></element-citation></ref><ref id="B108-pathogens-10-00091"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cegelski</surname><given-names>L.</given-names></name><name><surname>Marshall</surname><given-names>G.R.</given-names></name><name><surname>Eldridge</surname><given-names>G.R.</given-names></name><name><surname>Hultgren</surname><given-names>S.J.</given-names></name></person-group><article-title>The biology and future prospects of antivirulence therapies</article-title><source>Nat. Rev. Microbiol.</source><year>2008</year><volume>6</volume><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1818</pub-id><pub-id pub-id-type="pmid">18079741</pub-id></element-citation></ref><ref id="B109-pathogens-10-00091"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>M.</given-names></name></person-group><article-title>Quorum-sensing control in Staphylococci&#x02014;A target for antimicrobial drug therapy?</article-title><source>FEMS Microbiol. Lett.</source><year>2004</year><volume>241</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.femsle.2004.11.016</pub-id><pub-id pub-id-type="pmid">15598524</pub-id></element-citation></ref><ref id="B110-pathogens-10-00091"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piewngam</surname><given-names>P.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Nguyen</surname><given-names>T.H.</given-names></name><name><surname>Dickey</surname><given-names>S.W.</given-names></name><name><surname>Joo</surname><given-names>H.</given-names></name><name><surname>Villaruz</surname><given-names>A.E.</given-names></name><name><surname>Glose</surname><given-names>K.A.</given-names></name><name><surname>Fisher</surname><given-names>E.L.</given-names></name><name><surname>Hunt</surname><given-names>R.L.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Pathogen elimination by probiotic <italic>Bacillus</italic> via signaling interference</article-title><source>Nature</source><year>2018</year><volume>562</volume><fpage>532</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0616-y</pub-id><pub-id pub-id-type="pmid">30305736</pub-id></element-citation></ref><ref id="B111-pathogens-10-00091"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehi</surname><given-names>B.</given-names></name><name><surname>Fokou</surname><given-names>P.V.T.</given-names></name><name><surname>Sharifi-Rad</surname><given-names>M.</given-names></name><name><surname>Zucca</surname><given-names>P.</given-names></name><name><surname>Pezzani</surname><given-names>R.</given-names></name><name><surname>Martins</surname><given-names>N.</given-names></name><name><surname>Sharifi-Rad</surname><given-names>J.</given-names></name></person-group><article-title>The therapeutic potential of naringenin: A review of clinical trials</article-title><source>Pharmaceuticals</source><year>2019</year><volume>12</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.3390/ph12010011</pub-id><?supplied-pmid 30634637?><pub-id pub-id-type="pmid">30634637</pub-id></element-citation></ref></ref-list></back></article>